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order randomized by the instrument itself. (b) Two quadruplicated negative
controls were stored in the first column of each plate, and the other two qua-
druplicated positive controls were located in the last column. The remaining
columns were used for twenty quadruplicated mutant samples with genetic per-
turbations. The control samples were repeated in all the plates, but the mutant
samples were different in different plates. (c) An example uses the boxplot
for the first 18 plates of the screen to visualize the distribution of the scored
abundance of one element (i.e. Cadmium) for a positive control named as
YPR065W (or ROX1). Three plates were processed in a day termed as a batch.
It clearly indicates that there are systematic effects of plates and batches on the
phenotype. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.2 Effect of normalization on elemental abundance of Sulfur in the first control
of the knock-out screen in Chapter 3.4, BY4741, which was used for normal-
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ECDF, function of the gene rank. X-axis: p-value or 1 minus posterior prob-
ability. Solid line: two randomly selected replicates from a same condition
(AvsA). Dotted line: one randomly selected replicate from each condition
(unreplicated AvsB). Dashed line: AvsB on the full dataset for two-group de-
signs. Dashed-dotted line: AvsB on the full dataset for more complex designs.
Gray line: 45 degree. SAMseq is not applicable to unreplicated experiments
and is excluded. The desired patterns are high areas under the AvsB curves,
and AvsA curves that are at or below the 45 degree line. . . . . . . . . . . 60
3.4 Areas under the ROC curves of detecting differentially expressed genes for the
simulated datasets in Table 3.2. . . . . . . . . . . . . . . . . . . . . . . . 63
3.5 Areas under the ROC curves of detecting differentially expressed genes for the
experimental datasets with an external ‘gold standard’ in Table 3.2. . . . . . 64
3.6 The empirical cumulative distribution function (ECDF) curves of detecting dif-
ferentially expressed genes for the five datasets with no external ‘gold standard’
when shrinking the variance estimates. Y-axis: ECDF, function of the gene
rank. X-axis: p-value. Solid line: unreplicated comparison AvsA. Dotted
line: unreplicated comparison AvsB. Dashed line: AvsB on the full dataset
for two-group designs. Dotted-dashed line: AvsB on the full dataset for more
complex designs. Gray line: 45 degree. The curves are less consistent with the
expected patterns than the curves in the first column of Fig. 3.2. . . . . . . 66
4.1 The proposed score is close to 1 when miniXICs of the fragment share homo-
geneous peak shape, illustrated by peptide AAADALSDLEIKDSK in sample
s=1 and group g=1. Column 1 is the three-dimensional barplots of intensities.
Column 2 overlays the miniXICs (black lines) and the fitted lines (red lines)
with Eq. (4.1). The XIC plot of a fragment shown in column 3 is the total in-
tensity at each point in time based on the 3D barplot shown in column 1. The
X-axis in all the graph is the independent variable x in Eq. (4.1) and Eq. (4.2). 80
4.2 The proposed score gives high weight to the fragment as long as an apex ob-
served in only a partial peak, illustrated by peptide YAQDGAGIER in sample
s=6 and group g=2. Axes and labels are as in Fig. 4.1. . . . . . . . . . . . 81
4.3 The proposed score gives low weight to the fragment when its miniXICs have
flat pattern independently from the other fragments within the peptide AAQDSF
AAGWGVMVSHR in sample s=2 and group g=1. Axes and labels are as in
Fig. 4.1. The fragment with interference noise is illustrated in row (c). . . . 82
4.4 The proposed score is close to 0 when the interference noise is strong, illus-
trated by peptide SKLNDAVEYVSGR2 in a sample. Axes are as in Fig. 4.1. . 83
xiii
Figure Page
4.5 The proposed method succeeds in providing consistent weighting scores within
a sample or a fragment. The profile plots shown in this figure are fragments’
intensity versus sample index. A connected line in the plot is the profile of a
fragment. The first 3 samples are under condition A and the last 3 samples are
under condition B. This is illustrated by the profile plots of the four peptides
shown in Fig. 4.4-Fig. 4.3. The four peptides shown in Fig. 4.4-Fig. 4.3 are
presented in rows of this figure. It is shown that the weighting effect of mScore
is ignorable. Detailed information about the formulae and the interpretation are
provided in Chapter 4.3 and Chapter 4.3.3. The Y-axis in column 1 is the total
raw intensity under the XIC curve of a fragment. It is the dependent variable in
Eq. (4.9). The Y-axis in column 2 and 3 is the dependent variable in Eq. (4.10). 84
4.6 The total intensity adjusted by the proposed weight score improves the ac-
curacy of testing results upon this dataset. AB and AA label the comparison
between conditions and the comparison within conditions. m.AB and m.AA
are the quantification with estimated peak heights. mw.AB and mw.AA are
the products between peak heights and the weighting score. logCnt.AB and
logCnt.AA are the quantification with log of total count. logCnt_w.AB
and logCnt_w.AA are the products between logCnt and the weighting score
(see Chapter 4.3.3 and Chapter 4.4 for details). . . . . . . . . . . . . . . . 85
4.7 The comparison between per-fragment models and all-fragment models indi-
cates that they are competitive. (a) The smooth scatter plot of all-fragment
model vs per-fragment model indicates that the most of the scores are similar
since the majority is around the 40 degree line. The dark colored area at the
top right indicates that more fragments obtained the weight close to 1 using all-
fragment model than using per-fragment model. (b) The ECDF plot indicates
that the proposed score using per-fragment model helps to increase specificity
in tests and moderately sacrifice sensitivity compare all-fragment model. . 86
4.8 The proposed score outperforms the alternative score by increasing specificity
in tests. (a) In this smooth scatter plot, mScore is standardized to be compa-
rable with the proposed score. Details are provided in Chapter 4.3.3 The data
shown in this plot is already filtered so that all the fragments have strong coher-
ent pattern within the peptide. The purpose is to show that the proposed score
is complementary to the existing alternative. It further improves the accuracy
in test based on the filtration result from mProphet. (b) In the ECDF plot,
axes and labels are as in Fig. 4.6. Per-fragment model is used for the proposed
score. The ECDF curve of p-values for the within-condition comparison us-
ing the proposed score is much lower than the curve using the alternative. It
indicates the reduction of false discovery rate. . . . . . . . . . . . . . . . 87
xiv
ABBREVIATIONS
MLE maximum likelihood estimator
MM method of moments
DIA Data-Independence Acquisition
DNA deoxyribonucleic acid
ICP-MS Inductively Coupled Plasma spectroscopy combined with Mass Spec-
troscopy
IDA Information-Dependent Acquisition
MRM Multiple Reaction Monitoring for multiple SRM transitions
MS Mass Spectrometry
MS/MS tandem mass spectrometry
MS1 precursor mass spectra for peptides
MS2 tandem mass spectra for fragments of peptides
m/z mass-to-charge ratio
NGS Next-Generation Sequencing
RNA-seq whole transcriptome shotgun sequencing
SRM Selected Reaction Monitoring for quantitative proteomics
SWATH Sequential Window Acquisition of All THeoretical fragment-ion
spectra
XIC eXtracted Ion Chromatogram
xv
ABSTRACT
Yu, Danni Ph.D., Purdue University, December 2013. Estimation of Variation For High-
throughput Molecular Biological Experiments With Small Sample Size. Major Professor:
Olga Vitek.
Motivation: In the quantification of molecular components, a large variation can affect
and even potentially mislead the biological conclusions. Meanwhile, the high-throughput
experiments often involve a small number of samples due to the limitation of cost and
time. In such cases, the stochastic information may dominate the outcome of an experiment
because there may not be enough samples to present the true biological information. It is
challenging to distinguish the changes in phenotype from the stochastic variation.
Methods: Since the biological molecules have been quantified with different technolo-
gies, different statistical methods are required. Focusing on three types of important high-
throughput experiments, this thesis proposes novel solutions to reduce noise and increase
the accuracy of molecular discovery.
i) In the large-scale perturbation screens, thousands of mutant strains on hundreds of
plates are separately profiled in hundreds of days (or batches). For each mutant strain, only
a small number of samples are profiled. The artificial noise mainly consists of additive and
multiplicative effects due to plates and batches. We propose a linear mixed-effect modeling
framework based on experimental designs with at least two control samples. These are
involved in a normalization and variance estimation procedure for the purpose of reducing
the noise from data and scoring the true biological phenotype.
ii) In the RNA-seq experiments, fragments of greater than thousands of genes in 4∼8
samples on a flow cell can be sequenced in one day. The additive and no-additive effects due
to the large number of plates do not typically present in the data. The gene-wise variance
between samples consists of both the expectation and dispersion of gene counts. Due to
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stochastic noise, some of gene-wise dispersion are under or over estimated. This may
lead to misinterpretation of the biological phenotype. We propose a shrinkage estimator
of dispersion under Negative Binomial models to regularize the estimates towards a value
calculated from common information across genes.
Lastly iii) in the MS/MS experiments with SWATH acquisition, more than 10 thou-
sand spectra in a run can be sequentially obtained in about 120 minutes. The summed
up intensity across all the signals within a tiny m/z bin is used to identify fragments of
each peptide. As a result, the interference noise within the m/z bins leaves undetected
and misleading ambiguity in protein quantification. The solutions previously proposed for
perturbation screens and RNA-seq experiments can not be used for SAWTH acquisition be-
cause the property of the data is different. In order to remedy such defects, a new approach
is proposed to quantify the homogeneity (opposite to interference) among the co-elusion
traces of molecules within the m/z bins. Since correct signals of a fragment share a homo-
geneous peak shape, we propose to utilize the p-value of one-side test on the second order
coefficient in a linear quadratic model. The coefficient accounts for the curved shape in a
linear regression procedure. The p-value represents the strength of concave pattern across
those peaks of a fragment.
Results: The evaluation results of different experiments with each of the three tech-
nologies illustrate that the proposed solutions outperform several existing methods.
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1. INTRODUCTION
Genes and proteins are the fundamental molecules for living organisms. Biological infor-
mation saved by millions of DNAs on genes are transferred and utilized to produce pro-
teins [1]. Fulfilling their various functions leads to abundant changes of those molecules.
Consequently, the quantification studies of genes, proteins and the products of gene per-
turbations facilitate the discovery of functional genes in life science. However, the scored
phenotype consists of not only the biological changes but also sources of variation that
substantially affect the biological conclusions.
Since different techniques and experimental methods have been developed to account
for the various characteristics of genes and their products, it is challenging but required for
statisticians to accurately estimate and reduce the noise from data using different statistical
methods.
This thesis focuses on estimating the variation of quantitative phenotype collected in
three types of important high-throughput experiments. The souse of major variations are
carefully studied. We propose different and appropriate statistical solutions to reduce
noise in such experiments. Problems and contributions of these projects are introduced
in Chapter 1.1−Chapter 1.3. Two of these projects and the extended work have been pub-
lished [2–4].
1.1 Genome-wide perturbation screens
1.1.1 Statement of biological problem
A main purpose of studying the perturbation screens in this project is to identify the
changes in the elements’ abundance associated with the lost-of-function or over expression
of a gene. In the study of genome-wide perturbation screens, the phenotypes of thousands
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of such mutant samples are quantified under various conditions. Consequently, those scored
phenotypes are subject to both biological and technical variation.
In these experiments, it is practical to include a small number of replicates for each
mutant, such as n = 4, 8, 16. Randomizing the order of genome-wide mutant samples
throughout the screens removes the systematic pattern between plates. This is because
similar phenotypes may be obtained in the mutant samples when perturbing the genes close
to each other on a chromosome. To implement the experiment, an available instrument only
processes three 96-well plates in a day. Those mutant samples have to be distributed into
hundreds (e.g. 300 480) of plates and profiled in hundreds (e.g. 100 160 days) of days
(i.e. batches). It produces shifts and alters the scales of phenotype in different plates and
batches. These additive and non-additive random noise due to the large number of batches
and plates nested in batches must be addressed for accurate detection of hits.
1.1.2 Statement of statistical problem
A practical and implementable experimental design for the high-throughput perturba-
tions screens is required. The experiments should not only collect the biological informa-
tion in mutant samples but also facilitate the estimation of the additive and non-additive
variation between plates and batches.
For the purpose of reducing the noise, a statistical model is required to account for
the random effects in batches and in plates nested in batches. In addition to the additive
noise, the statistical mutant× batch interaction and the statistical mutant× plate interaction
should be used to account for the non-additive or multiplicative variation. However, the es-
timation of those parameters can not be directly obtained because currently it is impossible
to collect technical replicate measurements of each mutant sample in every plate.
1.1.3 Contributions
To solve the above-mentioned problems, the following procedure is proposed in [2].
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• We propose an experimental design that involves at least two negative quadruplicate
control samples. These control samples are repeated in all of the plates. For the
purpose of evaluation, we also recommend including the other quadruplicate control
samples and repeat them in all the plates. For a genome-wide perturbation screen,
mutant samples should be quadruplicated and nested in plates.
• A linear mixed-effect modeling fitted in the first negative control samples is proposed
to estimate the additive effects.
• Another linear mixed-effect modeling fitted in the second negative control samples
is proposed to estimate the non-additive effects.
• A score is proposed to summarize the biological phenotype of each mutant sample.
The score is based on the normalization after using the first model and the variance
estimation using the second model.
The extended work of obtaining biological conclusion based on the results in [2] is pub-
lished in [3]. The experimental datasets are published at www.ionomicshub.org. The open-
source R package HTSmix is available at http://www.stat.purdue.edu/∼ovitek/HTSmix.html.
1.2 RNA-seq experiments
1.2.1 Statement of biological problem
The digital counts of reads for gene expression are produced in RNA-seq experiments.
In one day, genome information can be obtained in a small number of samples nested in one
or several flow cells. The noise due to large number of plates and batches are not the major
concern in this project when the total number of samples are small. Instead, the stochastic
variation in genes and samples is the major focus.
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1.2.2 Statement of statistical problem
The gene abundance is quantified in counts. The traditional statistical methods for gene
expression analysis with microarrays may not be directly applied since the gene abundance
was based on a continuos variable.
Currently, the counts are frequently modeled by the Negative Binomial distribution.
The model is utilized to distinguish the systematic changes in gene expression between
conditions from noise. However, the per-gene estimates of the dispersion parameter is
often not reliable in the experiments with small sample size.
1.2.3 Contributions
The aim of our research is to provide a simple but effective approach for characterizing
the variation in the counts of reads, we propose in [4] to
• calculate the initial estimates for per gene dispersion using the method of moments,
• shrunk all the estimates towards the common information borrowed across genes,
• estimate such common information by the value within the range of initial estimates
that minimizes the average squared difference between the initial estimates and the
shrinkage estimates.
Without requiring extra modeling assumptions, the proposed method is computationally
efficient, and compatible with the exact test of differential expression. The open-source R
package sSeq is available at http://www.stat.purdue.edu/∼dyu/sSeq and Bioconductor.
1.3 MS/MS with SWATH aquisition
1.3.1 Statement of biological problem
The study of changes in protein abundance relies on the identification and quantifica-
tion of the peptides (i.e. fragments of proteins) at MS1 level or the fragments of peptides at
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MS2 level. In this project, we focus on the data collected in MS/MS with SWATH acqui-
sition, which is a novel technique based on data-independent approach. Given a spectral
library including the prior known targets, the fragments of peptides can be identified and
quantified based on the MS2 spectra. This method produces the results with reasonably
good sensitivity and specificity for protein/peptide identification [5].
However, in complex experiments with a large number of proteins, misleading informa-
tion can be produced by noise interference in the fragments that are identified as a peptide,
but actually from a different source. Such fragments often co-elute and share similar mass-
to-charge ratios (m/z). To distinguish the true information from the interference noise is
challenging.
1.3.2 Statement of statistical problem
The existing method such as openSWATH identifies the peptides based on the extracted-
ion chromatograms (XICs). Specifically in this project, a two-dimensional bin spans around
5 minutes in retention time and 50ppm in spectra. Counts of all the molecules observed in
the 50ppm window are summed up within each time point. Finally, the XIC of an identified
fragment consists of the total counts at each time point and a small range of retention
time. This existing method helps identify the peptides but leaves potential ambiguity into
the fragments’ quantification. This is because molecules within the 50ppm belonged to
different fragments can also produce high intensity in a XIC and encourage the plausible
identification.
Consistent peak pattern among those molecules is a key concept of judging a true frag-
ment. However, it is challenging to statistically model the shared pattern between those
molecules.
1.3.3 Contributions
To increase the accuracy of quantification within fragment and account for the interfer-
ence noise between mis-identified fragments, we propose to
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• separate the XIC of a fragment into miniXICs for the molecules within the 50ppm
window,
• model the association between retention time and the molecules’ intensity with one
quadratic regression,
• weigh the strength of peak shape pattern among the molecules using the p-value of
testing the second-order coefficient in the quadratic regression model, and then
• extend the quadratic regression by adding a fixed-effect factor (i.e. fragments), and
fit the model in the data including the miniXICs of all the identified fragments of a
peptide.
Evaluation results upon real experiments illustrate the quantification combined with the
proposed method empirically improves the sensitivity and specificity in comparative study
of detecting changes in protein abundance.
1.4 Outline
This dissertation is organized as follows. Chapter 2 describes the experiments of pertur-
bation screens, the related work and the proposed solution for noise reduction and variance
estimation in the quantification of element abundance. Chapter 3 presents the problems
of gene quantification in RNA-seq experiments and the proposed approach of regularizing
the dispersion estimates. Chapter 4 describes the data-independent acquisition experiments
with SWATH technology for protein quantification and proposes a statistical solution to
score the strength of concave pattern across traces of signals with fragments. Finally, the
results are summarized and future work is discussed in Chapter 5.
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2. GENOME-WIDE PERTURBATION SCREENS
2.1 Introduction
1 In functional biology [6,7], and in biomedical [8] and biopharmaceutical research [9],
the technology of perturbation screening [10, 11] has been used to observe a variety of
phenotype in model organisms subjected and associated to the stresses. Two major types
of perturbation are either external such as heat shock or chemical treatments, or internal
such as genetic disruption or deletion of genes. The measurement on the phenotypes can
be univariate (e.g. cell growth rate or activity of a reporter gene), low-dimensional (e.g
cellular morphology and ionomics), or high-dimensional (e.g. gene expression or protein
abundance). Insightful information on the function of living organisms [12, 13] can be
obtained when the perturbation study is performed in a genome-wide scale.
However, a primary concern in the investigations of genome-wide screens is how to
accurately quantify the sources of variation in these high-throughput data, and increase
the reproducibility between experiments. Because measuring the phenotypes of one-by-
one genetic perturbations takes several months when working with Inductively Coupled
Plasma Mass Spectrometry (ICP-MS), the fundamental principles of statistical methods
can not be directly utilized. Especially, there are typically very small number of repli-
cates (n=1, 2, 3, 4) incorporated in perturbation screens due to the limitation of instru-
ments. Fully randomizing the order or the replicates in genome-wide scale is impossible.
Furthermore, the problem compounded with different experimental characteristics such as
instruments, labor, and reagents can also not be removed from large-scale screens. Con-
sequently, the sources of variation existing in the measurements include both the natural
between-sample variation and the technical variation for handling samples and procedures.
It is an essential and non-trivial step to interpret and account for the specifics in such kind
1Copy rights are released with Publisher’s permission.
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of high-throughput perturbation screens. It is particularly challenging in such situations to
distinguish the systematic signal from noise.
In this chapter, we focus on the problem in cases of low-dimensional phenotypes which
are sensitively affected in an non-ignorable proportion of the samples. We propose a frame-
work with statistical modeling [2] to reduce the noise and accurately interpret the pheno-
types in high-throughput screens that have a limited number of replicates.
2.2 Background
The five steps involved in the study with perturbation screens are experimental design,
normalization, phenotype summarization for each sample over multiple replicates with es-
timation of the associated variation, determination of “hits", i.e. samples with systematic
changes in phenotype, and evaluation. Details about these steps are provided in the follow-
ing paragraphs.
2.2.1 Experimental design
We overviewed a typical design of a perturbation screen in Fig. 2.1. Among the types of
microtiter plates (e.g. 6, 24, 96, 384, or 1536 sample wells), the 96-well plates are typically
used by the ICP-MS instrument to balance the work load of a labor and the control of
environmental effects. In order to obtain high throughput, only a small number of replicates
for each mutant samples can be profiled, such as four replicates per sample nested in a plate
(recommended by [14]). To remove the variation due to the interaction between sample
and plate, all the replicates of a sample are systematically allocated to the same plate.
To enable genome-wide perturbation screening, hundreds or even thousands of plates are
required. Therefore, due to the limitation of biological material and capacity of equipment,
it is necessary to handle those large numbers of plates in batches.
In [15], it is observed that the batches-and-plates effect can systematically distort the
scored phenotypes. The variation in rows and columns on a plate [15] or the excessive
evaporation of media around the edges [16] produce the within-plate effects. These artifacts
9
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Fig. 2.1.: Experimental design of a perturbation screen.
(a) An instrument processes three plates in a day. The plate has 96 wells in which the
abundance of 14 or 17 elements were measured one-by-one in the order randomized by the
instrument itself. (b) Two quadruplicated negative controls were stored in the first column
of each plate, and the other two quadruplicated positive controls were located in the last
column. The remaining columns were used for twenty quadruplicated mutant samples with
genetic perturbations. The control samples were repeated in all the plates, but the mutant
samples were different in different plates. (c) An example uses the boxplot for the first 18
plates of the screen to visualize the distribution of the scored abundance of one element
(i.e. Cadmium) for a positive control named as YPR065W (or ROX1). Three plates were
processed in a day termed as a batch. It clearly indicates that there are systematic effects
of plates and batches on the phenotype.
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can be accounted for using one or more control samples included in all plates. Those
control samples should be negative, i.e. the samples are not perturbed and naturally survive
in the wild environment, or positive, i.e. the samples are known to have changes in the
phenotype. In order to limit the artificial effects of evaporation on the perturbed mutant
samples, it was recommended [15] to allocate the controls samples around the edges of
each plate.
In practical study with high-throughput perturbation screens, due to the limited capacity
of plates, the absence of between-plate replication, and the small number of within-plate
replication of perturbed samples and control samples, it is challenging to eliminate the
experimental artifacts for accurate quantification on phenotype. In this chapter Chapter 3.3,
we argue that several existing statistical methods have not well used the control samples in
these situations. By separately using two or more distinct positive or negative controls, we
are able to obtain a more specific detection of hits.
2.2.2 Normalization
After samples are processed by an instrument, the outlying measures or died samples
are eliminated for quality control. In order to have the measured phenotype comparable
across samples, batches and plates, a normalization procedure is required to account for
confounding and experimental artifacts.
Sample-based and control-based are two approaches of normalization that are frequently
used. By assuming that the majority of perturbations do not affect the phenotype, sample-
based normalization methods normalize to a pool of samples. The examples such as B-
score [17], Z-score, and plate-wise median [18] are shown as follows. Those methods were
reviewed in [15] and shown as follows.
B score specifies a linear model when the additive effects of rows and columns, Ri,p and
Cj,p, within plate p exist in model Eq. (2.1),
Xij,gkp = µp +Ri,p + Cj,p + εij,gkp, (2.1)
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where the average phenotype within plate p is denoted by µp, Xij,gkp is the intensity of
replicate k of mutant g on row i and column j in plate p, and the non-systematic error
εgkp ∼ N (0, σ2gkp). Separately for each plate, all the measurements within a plate are
used to estimate the parameters in Eq. (2.1). Using a robust method for sample averages
(i.e. Tukey median polish), the residue between the scored phenotype and the estimated
expectation is obtained in Eq. (2.2). Finally, a B score for the kth replicate of mutant g in
plate p is the model residuals in the unit of its median absolute deviation.






Z score is the difference between the scored phenotype and the average of all samples
within a plate, which is then scaled in the unit of plate-specific standard deviation. In






Plate-wise median normalization (pmNorm) is just the scored phenotype in the unit of





Quantile normalization is a method popularly utilized for gene expression in microar-
rays experiments [19,20]. The method is extended to perturbation screens [21] for normal-
ization between plates. It assumes that phenotypes between plates share the same empirical
distribution G. The observed phenotype Xgkp is firstly transformed into G and then re-




The other sample-based normalization methods can be utilized to account for the batch
effect, such as principle analysis [22], and surrogate variable analysis [23].
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Since sample-based normalization uses the entire collection of samples in the pertur-
bation experiment, it maximizes the degree of freedom for parameter estimation and pro-
duces an accurate output of the normalized phenotype. However, in the situation when a
large number of perturbations affect the phenotype and especially when the secondary and
confirmatory screens are performed, the assumption of sample-based normalization is not
appropriate. As an alternative, control-based normalization should be used [24]. Descrip-
tion on several existing control-based normalization is provided here.
Normalized percent inhibition (NPI) quantifies the inhibition with the difference be-
tween mean of positive controls’ phenotype c̄+p and a sample’s scored phenotype Xgkp in
the unit of difference between mean of positive controls and mean of negative controls c̄−p .





Percent of control mean (pocMean) in Eq. (2.8) normalizes sample phenotype Xgkp to
mean of positive controls c̄+p by considering the measurements of positive controls as a
baseline in each plate. Percent of control median (pocMed) formularized in Eq. (2.9)
normalizes sample phenotype to median of negative controls c̃−p with the information that
those controls do not affect the phenotype. Since negative controls are often affected by









In perturbation screen, each plate only can include a small number of controls. The
existing normalization method based on controls only account for limited types of experi-
mental artifacts. As a result, highly variable estimates of bias can not be eliminated. The
performance of seven sample-based and control-based normalization methods were com-
pared in [16]. As a conclusion in the words of [24], “no single method excelled" in all sit-
uations. The softwares, such as the open-source Bioconductor packages RNAither [25]
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and cellHTS2 [26], offer the implementation for several above-mentioned normalization
methods.
In this chapter, it is demonstrated that, compare to several existing methods, we are able
to improve the accuracy of results using control-based normalization for the experiments
in which a large proportion of samples with changed phenotypes are shown in screens. We
argue that at least two controls should be involved, one used for normalization and another
one used for estimation of between-plate variation.
2.2.3 Summarization of phenotypes, and estimation of variation
In order to borrow information across all the samples in genome-wide perturbation
study, a comparable summarizing score over the replicates for a biological sample needs
to be provided such as an averaging value. Meanwhile, it is also important to estimate the
associated variation, which enables us to distinguish random variation from perturbation-
related changes in the phenotype. Sample variance or its robust alternatives are the esti-
mator that most existing methods have used [18]. The other method, such as Empirical
Bayes approach for variance stabilizzation recommended in [15], is directly applicable to
the context of perturbation screens. The approach was originally introduced in the study of
gene expression with microarray experiments [27, 28].
However, when there are not between-plate replicates in genome-wide study, the above-
mentioned methods for estimation of variation can have serious deficiencies affected by the
unknown and potentially sensitive phenotypes. In such kind of experiments that allocate
all replicates of a biological sample in the same plate, only the estimates of within-plate
variation can be provided. Those methods actually assume that the variation in a plate is
enough to account for the entire between-plate variation in the normalized phenotypes.
In Chapter 2.3.3, we demonstrate that this assumption over-simplifies the structure of
variation in high-throughput perturbation screens. and this problem is rarely verified in
previous literature. We also note that estimates of plate-and batch-specific bias are subject
to uncertainty when normalizing quantities are estimated from a small number of obser-
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vations. Moreover, in different biological samples, the plate-and-batch-specific effect on
the phenotype can be different. It further contributes to the variation. We illustrate that it
is important for accurate determination of hist to account for this residual variation in an
appropriate way.
2.2.4 Determination of hits
The certain value µ0 that is compared in a null hypothesis Ho : µg = µ0 is typically
the phenotype of a control or the average phenotype of all stressed samples, where µg is
the average phenotype over replicates of one perturbation sample. A test statistic, such
as the Student T or the moderated T, is utilized to compare the summary quantification of
the phenotype with its estimate of variation. Depending on the experiment, the reference
distribution of the statistic is assumed as Student or Normal, or is estimated empirically
based on controls. Non-parametric alternatives , e.g. the Mann-Whitney test and the Rank
Product test [25] can also be used, but the power is lower.
Student T statistic is based on the summarization by sample average, and on variance









(vgkp − v̄g··) (2.10)
where ng is the number of replicates of mutant g in plate p.
Moderated T statistic was originally proposed in the context of gene expression mi-
croarrays [27], and improves upon the estimate of variance s2g for experiments with a small
number of replicates. The approach assumes a Scaled Inverse Chi-square prior distribu-
tion of σ2g (or, equivalently, an Inverse Gamma distribution), and uses an Empirical Bayes



















, where s̃2g =
(ng−1)s2g+d0s20
(ng−1)+d0 . (2.12)
s20 and d0 in the expression above are the degrees of freedom parameter and the scale pa-
rameter of the prior distribution, which are estimated empirically from the entire collection
of mutants in the screen. In other words, the joint analysis of all the mutants provides an
additional information on the variation, and is equivalent to a prior dataset with estimated
variance s20 based on d0 degrees of freedom.
After calculating the test statistics, it is a non-trivial problem to select cutoff for de-
termination of hits and control the rate of false positive hits at the desired level. Methods
in multiple testing procedures such as [29] or [30] can be directly used for controlling the
False Discovery Rate (FDR). As an alternative, a specialized Bayesian procedure was de-
veloped in [31] to directly model the probabilities of phenotypes and controls FDR. In [32],
ordered Z scores was designed by a tool called RNAiCut for automated identification of
pathway-relevant hits. Although all these approaches are appropriate, the choice of the test
statistic and its estimate of variation directly affect their sensitivity and specificity.
2.2.5 Evaluation
Since the true biological information is typically unknown in experimental datasets,
evaluating the performance and efficacy of methods is challenging. We take the advantage
of multivariate phenotypes in the situation where Pearson correlations of summarized phe-
notypes between replicate plates for one control measure the reproducibility of biological
samples. If a method accurately and appropriately process the perturbation screens, the
reproducibility should be high and the evaluation value should be close to 1. Other wise,
the value is close to 0 and the method is plausible. Such multivariate phenotypes of both
control-based and sample-based are used for evaluation in Chapter 3.5.
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2.3 Methods
We focus on high-throughput perturbation screens with one-dimensional or low-dimensional
quantitative phenotypes in this chapter. Specifically we illustrate the proposed method
with experiments of genetic perturbations, and refer to the screened samples as mutants.
However, the discussion is applicable to all perturbation types. The highly disruptive per-
turbations or sensitive phenotypes, where we cannot expect a small number of hits, are
particularly considered.
The proposed method is a stepwise interpretation procedure based on linear mixed-
effects models. This stepwise modeling is computationally efficient compare to global
mixed-effects modeling that fits the entire dataset. The approach of stepwise procedures
was successfully applied in the context of gene expression microarrays [33, 34], and is
similarly effective for perturbation screens.
2.3.1 Experimental design
The experiments that we utilize to illustrate the methods were processed in 96-well or
similar plates. All replicates of a sample were profiled in the same plate. Suggested in [15],
all within-plate allocations of samples, and a small number of biological replicates, e.g. 4
recomended by [14], can be used.
The proposed approach requires the presence of more than one control samples, profiled
in all batches and all plates. Normalization of the phenotype across batches and plates uses
the first control. Estimate of the associated variation uses the second control to derive the
summary statistic for each mutant. It is beneficial for evaluation if one or two additional
control samples, complementing the previous two, are also profiled.
2.3.2 Normalization
Basic model-based normalization. A scored univariate phenotype is denoted as Xgkbp,
where g is the index of the mutant in which a specific gene was perturbed, k is the index
17
of a replicate for that mutant g, b is the batch index and p is the plate index where the
mutant replicate k was located. In the situation that multivariate phenotypes are profiled
for each sample, we consider each dimension separately, and use the convention that Xgkbp
represents one particular dimension.
Technical variation such as batches and plates, and biological variation are the major
sources of variation in a screen. In the normalization model we assume that these effects
are non-systematic Normal random variables represented in the following linear model
Xgkbp = µg +Bgb + P (B)gp + εgkbp (2.13)
Bgb
iid∼ N (0, σ2Bg), P (B)gp
iid∼ N (0, σ2Pg), εgkbp
iid∼ N (0, σ2εg)
where Xgkbp is the intensity of replicate K of mutant g on plate p nested in batch b, Bgb is
a random factor due to batch effect, P (B)gp is a random factor due to plate effect nested
within batches, and εgkbp is the random factor due to model error, and it includes the rest of
biological and technical variation that the other two random variables do not account for.
All the three random variables in Eq. (2.13) , Bgb, P (B)gp and εgkbp, are independent of
each other. Particularly, g=1, 2, 3, 4, represent the indexes for the first, second, third and
fourth controls, respectively. And g=5, 6, 7, ...... represent the indexes for mutants.
It is applicable to estimate µ1, Bgb and P (B)gp with a sample-based approach, i.e.
using all the samples in the batch or plate. However, such estimation can produce biased
estimates for the screens with disruptive perturbations or sensitive phenotypes. Therefore,
we use control-based normalization, and estimate µ̂1, B̂1b and P̂ (B)1p by fitting the model
in Eq. (2.13) to the first control (i.e., to biological samples with g = 1 in the notation
above). On the other hand, adding all the negative control into the normalization model
produces extra statistical factors due to the difference between control samples. Part of this
extra variation goes into the model error and affects the accuracy of estimating the plate and
batch effect. Consequently, we use one control sample instead of multiple control samples
to avoid the extra variability that is not caused by the plate and batch effects.
In linear mixed models, such estimates are typically obtained by maximizing the re-
stricted/residual maximum likelihood (REML) using Expectation-Maximum (EM) or Newton-
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Raphson algorithms. The ridge-stabilized Newton-Raphson algorithm allows a faster con-
vergence [35], and we use this algorithm as implemented in the R package lme4. The
unbiased estimation of variances σ2P1 , σ
2
B1
and σ2ε1 are derived. We normalize the scored
phenotype of mutants to the first control (g = 1) by subtracting its estimated batch- and
plate-specific deviations B̂1b and P̂ (B)1p from the scored phenotypes of mutants (g = 5,
6, 7, ......). In Eq. (2.14), the normalized phenotype for the kth replicate of the gth mutant
located in the bth batch and on the pth plate is denoted as rgkbp.
rgkbp = Xgkbp − [B̂1b + P̂ (B)1p], (2.14)
Extensions. We develop the above-mentioned linear mixed-effect model as a flexible al-
ternative that can be extended in various ways to account for within-plate effects, confound-
ing effects, or time-dependent correlation effects. For example, if the position of a mutant
at columns and rows within a plate systematically change the phenotype, then similar as
B-score in Eq. (2.1), the row factor and column factor can be included in the normalization
models shown as follows.
Xij,gkbp = µg +Rip + Cjp +Bgb + P (B)gp + εgkbp, (2.15)∑
iRip = 0,
∑
j Cjp = 0,
P (B)gp
iid∼ N (0, σ2Pg), Bgb
iid∼ N (0, σ2Bg), εgkbp
iid∼ N (0, σ2εg)
where Xij,gkbp is the intensity of kth replicate of gth mutant on pth plate nested in bth batch,
Rip and Cjp are the estimated effects due to the ith row and the jth column on the pth plate.
The remaining notation is kept same as those in Eq. (2.13). When only a small number of
distinct mutants [36] are included in rows or columns, a lowess-based smoothing of these
effects can be used.
For another example, we can also extend the proposed model to account for confound-
ing effects on the scored phenotypes, such as growth rate of the mutants. Firstly the nor-
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malization model in Eq. (2.13)-Eq. (2.14) can be utilized to obtain the estimated effects due
to batches and plates relative to the scored growth rate GRgkbp.
GR1kbp = µ1 +B1b + P (B)1p + ε1kbp (2.16)
grgkbp = GRgkbp − [B̂1b + P̂ (B)1p], (2.17)
And then a linear model can be fit to estimate a single linear relationship between the
normalized confounding factor grgkbp and the normalized phenotype of mutants across all
the biological samples.
rgkbp = β0 + β1grgkbp + εgkbp, εgkbp
iid∼ N (0, σ2εg) (2.18)
The normalized phenotype that account for the confounding factors are obtained as
r′gkbp = rgkbp − β̂1grgkbp (2.19)
The normalized phenotypes are comparable across mutants. For the experimental datasets
detailed in Chapter 3.4, because we did not identify substantial within-plate effects due
to rows and columns in the step of quality control, the basic normalization in Eq. (2.13)-
Eq. (2.14) and the adjustment for growth rate in Eq. (2.18)-Eq. (2.19) are used in this thesis.
2.3.3 Estimation of variation and summarization
Illustrated in Fig. 2.2 - Fig. 2.3 that are boxplots of the normalized Sulfur accumulation
phenotype for three controls in hundreds of plates based on the knock-out screen (KO)
described in Chapter 3.4, we argue that the extra variation remained in the normalized
phenotype is required to be estimated and then applied into the summary score for each
mutant.
We used the first control, shown in Fig. 2.2, to derive batch- and plate-specific changes
of phenotype B̂1b and P̂ (B)1p. The left and right panels are the before normalization pheno-
types X1kbp and the after normalization phenotypes r1kbp. In the right panel, the Plate-wise
means are on a horizontal straight line. It means that the systematic between-batch and
between-plate variation is removed from the first control.
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The normalized phenotype for the other two controls in Fig. 2.3 are not used to estimate
the normalization parameters. Although the normalization removed large artifacts, such as
the outlying measurements in the left panel are adjusted and then a systematic horizontal
pattern is obtained in the left panel, the normalization step do not entirely eliminate all
between-batch and between-plate deviations. The differential effect of batches and plates
on mutant phenotypes produces such residual variation. The source of the residual variation
can be the non-additive effect of interaction factors (i.e. between batch and mutant, and
between plate and mutant), as well as the uncertainty in estimation of B̂1b and P̂ (B)1p
upon a small number of replicates in a plate.
When all replicates of mutants are repeated in all plates, the interaction factors can be














































Fig. 2.2.: Effect of normalization on elemental abundance of Sulfur in the first control of
the knock-out screen in Chapter 3.4, BY4741, which was used for normalization. The left
is the boxplot of Sulfur abundance before normalization. The right is the boxplot after
normalization. Y axis: raw or normalized abundance. X axis: plate id. The figures show
boxplots of the phenotype in 305 plates, indicating batches by colors, similarly to panel (c)
of Fig. 2.1.
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or by using alternative approaches [22]. However, in large-scale perturbation screens where

































































































Fig. 2.3.: Effect of normalization on elemental abundance of Sulfur in the second (top
row) and third control (bottom row) of the knock-out screen in Chapter 3.4, YDL227C and
YLR396C, which are not used for normalization. The Y and X axes are the same as the
axes in Fig. 2.2. The normalization procedure reduces the systematic differences between
batches and plates, however still leave residual variation in the normalized values.
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action effects cannot be estimated directly. Simply omitting the interaction effects can
seriously underestimate the overall variation, and undermine the accuracy of the results.
Therefore, we propose to account for the residual variation in normalized phenotypes










iid∼ N (0, σ2P ′g), B
′
gb
iid∼ N (0, σ2B′g),
ε′gkbp
iid∼ N (0, σ2ε′g), for g = 2, 3, 4, 5, ...
where r′gkbp is the normalized phenotype of sample g accounting for the confounding effect
such as due to growth rate, and the remaining notation is same as in Eq. (2.13).
The summary phenotype of mutant g is represented by µg, and its estimate is equivalent
to the average of the observed phenotypes over all replicates r̄′g require all replicates for a
mutant are nested in single plate. The associated estimated variation is
V̂ ar(r̄′g) = (σ̂
2
P ′g




where ng is the number of replicates for mutant g. The sample variance s2ε′g is used to
estimate parameter σ̂2ε′g . However, since there are no across-plate replicates for mutants,
σ2P ′g and σ
2
B′g
are not estimable directly.
Under the assumption that the control-based estimates accurately represent the residual
variation of all the biological samples in the screen, we propose to utilize the information
from one or several additional controls. In our practice the assumption can be plausible, and
yields accurate results. In the situation where this assumption deviates from the characteris-
tics of a screen, the experimental design has to be changed and the between-plate replicates
need to be profiled. However the design substantially decreases the throughput and can be
difficult to quantify large-scale perturbations in practice upon existing technologies.
These controls used for estimation of residual variance are not previously used in the




σ̂2P ′g + σ̂
2
B′g
≈ σ2P ′2 + σ
2
B′2
for g = 3, 4, 5, 6, ....... (2.21)
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When fitting Eq. (2.20) to the normalized phenotype of the second control such as shown
in Fig. 2.3, the ratio between variance of factors and variance of model error is about (σ̂2B′2 +
σ̂2P ′2
)/σ2ε′2
≈ 0.23 using the R package HTSmix. It measures the relative importance of the
residual variation. Furthermore in Chapter 2.5.2 we illustrate that the changes in results
using the proposed procedure is low when selecting different controls for normalization
and variance estimation.
2.3.4 Determination of hits
Hypothesis and test statistic. The typical hypothesis for a mutant in perturbations screens
H0 : µg = µ0 versus H0 : µg 6= µ0. The reference value of µ0 can be obtained based
on controls to test H0 : Phenotype of mutant g is consistent with the phenotype of controls
against Ha : Phenotype of mutant g is systematically larger (or smaller) than the phenotype
of controls [10, 15].
However, when the majority consists of disruptive perturbations or sensitive phenotypes
in the experiments, an unpractically large number of hits can be produced in testing. In this
case, we consider the reference value µ0 with sample-based approach. The test hypotheses
are verbalized as follows.
H0 : µg is consistent with the median phenotype of all mutants
Ha : µg is systematically larger or smaller than the median phenotype of all mutants
We calculate the test statistic shown in Eq. (2.22) that measures the normalized pheno-








Compared to the regular (or moderated) T-statistic, the denominator in Eq. (2.22) σ̂2P ′2 and
σ̂2B′2
incorporated by Dg, is more conservative. Therefore we are able to obtain fewer hits.
The sampling distribution of Dg is approximately Normal when assumptions in Eq. (2.13),
Eq. (2.20) and Eq. (2.21) are satisfied. The average ofDg over all mutants is not necessarily
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0 but very close to zero. The nature of the effects in the screen decides the center and the
scale of the distribution.
Controlling FDR in the list of hits. We apply Efron’s approach in [30] to produce a
list of hits while controlling the False Discovery Rate (FDR). The assumption of Efron’s
approach is that the test statistics Dg with non-systematic changes are generated from the
same distribution. A mixture of distributions under H0 and Ha can be modeled by the
sampling distribution of Dg. According to [30], we further standardize Dg to ensure that
its sampling distribution under H0 can be represented by the Standard Normal distribution
with mean as 0 and standard deviation as 1, i.e.
Zg =
Dg −median(Dg)
median( |Dg −median(Dg)| ) · C
(2.23)
where the normalizing constant required for a robust unbiased estimation of the scale [37]
is C = 1/Φ−1(3/4) ≈ 1.4826. The approach in [30] is implemented with the R package
locfdr. A Normal distribution is fitted to the center of the histogram of Zg, and the
two-side cutoff of Zg can be obtained to control the FDR under 0.05.
The distributions of Zg for multivariate phenotypes are comparable across dimensions.
Therefore, we can combine all dimensions in a single distribution to optimize the quality
of fit. When the assumptions in Eq. (2.13), Eq. (2.20) and Eq. (2.21) are satisfied, the
distribution of Zg under H0 is approximately Standard Normal. In Fig. 2.4, it is illustrated
by the three different perturbation experiments that the sampling distributions of Zg are
close to normal and no gross departures from the assumptions are observed.
2.4 Experimental datasets
Perturbation screens. The performance of the proposed approach is illustrated using
three large-scale genetic perturbation screens of S. cerevisiae (baker’s yeast). 1) The fully
knock-out (KO) data involves the 4940 open reading frames in haploid cells that were
fully silent one-by-one. 2) The partially knock-out (KOd) data involves 1127 open reading
frames in diploid cells, in which one of the two copies of the gene was silent so that the
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(a) KO screen, all elements (b) KOd screen, all elementsKOd: all elements

















fitted curve thresholds 
 (−3.158, 3.293)
1303 (26.38%) 
















fitted curve thresholds 
 (−3.413, 3.443)
148 (13.13%) 
 of 1127 mutants
range 
[−10.789, 8.591]
(c) OE screen, all elements
KOd: all elements


















fitted curve thresholds 
 (−3.734, 3.686)
964 (16.63%) 
 of 5798 mutants
range 
[−12.624, 40.407]
Fig. 2.4.: Determination of hits in three perturbation screens in the main manuscript. The
histograms show the sampling distributions of Zg in Eq. (2.23), combined across all di-
mensions of the multivariate phenotype. The dashed line showed the Standard Normal
distribution fitted to the center of the distribution, and the green line shows the fit to the
histogram based according to the two-group model in (Efron, 2008). Magenta triangles
indicate the thresholds of Zg, which control the FDR at 0.05.
26
perturbed cells still survive and grow. These mutant lines correspond to lethal disruptions in
the haploid lines. 3) The over-expressed data OE involves the full collection of 5770 viable
mutants in which each of the open reading frames is expressed at a higher than normal level.
For all the three experiments, the mutants were incubated in a series of 96-well plates, with
4 (rarely 8 or 16) replicates per strain.
Abundance of the yeast ionome is the phenotype of interest in these screens. Mineral
nutrient and trace element composition are the ionome of an organism [38, 39], including
macronutrients (i.e. P, Ca, K, Mg); micronutrients essential for plant and human health
(i.e. Cu, Fe, Zn, Mn, Co, Ni, Se, Mo, Cl); and minerals causing agricultural, environmental
or health problems (i.e. Na, As, and Cd). To quantify each element [2], “a common yeast
growth media was supplemented with additional elements, and each sample was processed,
in batches of 3 plates, using inductively coupled plasma spectroscopy combined with mass
spectroscopy (ICP-MS). Peaks in the spectra were signal-processed, and the absolute quan-
tification in parts per billion (ppb) obtained through the use of calibration standards as
described in [40]. A quality control procedure removed failed and outlying samples. Over-
all, the KO and KOd screen yields the multivariate phenotype of 14 elements, and the OE
screen yields the multivariate phenotype of 17 elements for each mutant."
Two negative and two positive control strains are included by each of the three exper-
iments, which are 1) BY4741, YDL227C, YLR396C and YPR065W for the KO screen,
2) BY4743, YDL227C, YLR396C and YPR065W for the KOd screen, and 3) YMR243C,
YDL227C, YBR290W and YGL008C for the OE screen. Four replicates for each control
strains were repeatedly add on all the plates. We selected the positive controls according
to the results in [41]. The observable changes were found in key elements such as Ni60,
Cd111 and S34 for these selected positive strains. They are helpful for us to test the ability
of identifying such known changes in phenotype.
In the step of quality control for the ionomic profiles , we did not identify any signifi-
cant spatial effect due to rows and columns within-plate effects detailed in Chapter 2.5.1.
However, "it was established that differences of growth rates between mutants could act
as potential confounders of the ionomic phenotypes" [2]. To account for the effect due to
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different growth rates, all the samples and controls were quantified by the sample optical
density (OD) with an OpsysMR plate reader (DYNEX Technologies, Chantilly, VA, USA).
They are publicly available at www.ionomicshub.org.
A large number of mutations is expected to affect the ionomic phenotype since the
elements constitute an integral part of most biochemical processes. Identifying the genes
that has significantly stronger impact on at least one element abundance than its median
overall all mutants help us discover the most important functional compounds.
2.5 Results
2.5.1 Rows and columns of the plate have negligible effect on the quantitative io-
nomic phenotypes.
We fit the additive model Eq. (2.1) to all the samples in a plate, separately for each plate.
The quality control metrics for the plate are then defined as the median absolute deviation
(MAD) of model-based estimates R̂i,p and Ĉj,p relative to the median absolute deviation of
the residuals rgkp in Eq. (2.2).
MADip(R̂i,p)/MADijp(rgkp) and (2.24)
MADip(Ĉj,p)/MADijp(rgkp) (2.25)
The boxplots shown in Supplementary Materials in [2] visualized the distributions of the
quantities in Eq. (2.24) and Eq. (2.25) over all plates, separately for each inorganic element
and each ionomic screen. Similar to row and column effects, and medians of the boxes
vary deviations within 1. This indicates that the row and column effects may include the
interesting phenotype variation, and the artificial effect due to rows and columns are not
significant. Therefore, the column and row factors for Eq. (2.15) were not included for the
three ionomic screens.
28





















































(a) Before normalization. Average: 0.558.
















































(b) After normalization using proposed methods. Av-
erage: 0.968.






















































(c) After normalization with B score and standardiza-
tion with moderated T. Average: 0.640.



















































(d) After normalization with NPI and standardization
with moderated T. Average: 0.438.
Fig. 2.5.: Profile plots of the standardized phenotypes of the control YLR396C in the KO
screen, which has not been involved into normalization or standardization. X axis: inor-
ganic elements. Y axis: (a) raw and (b)-(d) normalized and standardization phenotypes.
Each line represents the phenotype of the control in one plate. In each profile plots, there
are 305 lines corresponding to the phenotype of a control independently quantified in 305
plates.
2.5.2 Evaluation based on controls
The normalization procedure in Eq. (2.13) utilizes the information of the first negative
control g = 1 (i.e. BY4741 for KO, BY4743 for KOd, and YMR243C for OE). The
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procedure of estimating the variation in Eq. (2.20) is based on the second negative control
g = 2 (i.e. YDL227C for KO, YDL227C for KOd, and YDL227C for OE). The other two
Table 2.1: Averages of Pearson correlations between profiles in pairs of plates after nor-
malization and summarization. The values shown in the table were obtained based on the
positive controls that were repeatedly measured in all the plates. They are not involved
in normalization and estimation, and utilized for the purpose of evaluation. Higher values
illustrates better noise reduction. (a) Normalization by B-score, standardization by Moder-
ated T; (b) Normalization by Z-score, standardization by Moderated T; (c) Normalization
by plate-wise median, standardization by Moderated T; (d) Normalization by Percent of
positive controls, standardization by Moderated T; (e) Normalization by Percent of neg-
ative controls, standardization by Moderated T; (f) Normalization by Normalized percent
inhibition, standardization by Moderated T; (g) Quantile normalization, standardization by
Moderated T; (h) Proposed mixed-effect modeling for normalization with Eq. (2.13-2.14,
2.18-2.19), and standardization with Eq. (2.20-2.23). The methods in (a) - (g) are detailed
in Chapter 2.3.2
Averages of pairwise Pearson correlations between plates
(1) KO screen (2) KOd screen (3) OE screen
YLR396C YPR065W YLR396C YPR065W YBR290W YGL008C
Existing methods:
(a) B score 0.640 0.720 0.889 0.825 0.491 0.331
(b) Z score 0.765 0.776 0.910 0.817 0.530 0.361
(c) Plate-wise median 0.738 0.819 0.915 0.835 0.595 0.481
(d) PocMean 0.666 0.670 0.875 0.729 0.626 0.523
(e) PocMed 0.765 0.806 0.896 0.834 0.554 0.424
(f) NPI 0.438 0.508 0.689 0.686 0.759 0.595
(g) Quantile 0.696 0.772 0.857 0.917 0.630 0.485
Proposed methods:
(h) Mixed model 0.968 0.971 0.963 0.940 0.962 0.961
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positive controls are used to evaluate the quality of the results, which are YLR396C and
YPR065W for KO, YLR396C and YPR065W for KOd, and YBR290W and YGL008C for
OE.
Normalization and variance estimation: univariate phenotypes. The boxplots (Sup-
plementary 1 in [2]) similar to Fig. 2.2 − Fig. 2.3 were visually checked for controls in all
screens, and for the phenotypes of elements, before and after normalization with Eq. (2.13-
2.14, 2.18-2.19). Illustrated by those figures, we observed that the proposed methods are
able to remove the systematic trend in element abundance and obtain horizontal pattern
across plates.
Boxplots of the normalization results using B score (Supplementary 2 in [2]), Z score
(Supplementary 3 in [2]), and Normalized Percent Inhibition (Supplementary 4 in [2]) were
also presented. These methods also eliminated the systematic trends across plates. How-
ever, the scale of the phenotype are changed, and then it is not straightforward for a relative
comparison within or between dimensions. The multivariate phenotypes are utilized to
illustrate problem and shown in the following paragraph.
Normalization and variance estimation: multivariate phenotypes. The relative effi-
ciency of noise reduction procedures can be additionally evaluated by multivariate pheno-
types. Since the significant difference in normalized phenotypes between plates within the
same control is not biological meaningful and indicates poor reproducibility, we utilize the
pattern of standardized multivariate phenotypes within controls between plates to evaluate
the results of normalization and variance estimation. As compared to the mean phenotype
in each dimension, a tighter pattern indicates a better elimination of the residual batch- and
plate-specific variation.
The profile plots of the standardized phenotypes in Fig. 2.5 are for one positive control
in the KO screen. Fig. 2.5 summarize the between pattern of 14 dimensional phenotype for
the control when gene YLR396C was knockout. Fig. 2.5 (a) is before normalization, (b) is
after the proposed normalization with Eq. (2.13-2.14, 2.18-2.19), and standardization with
Eq. (2.20-2.23), (c) is after sample-based normalization with B-score and standardization
31
with moderated T statistic, (d) is after normalization with control-based Normalized Per-
cent of Inhibition (NPI) and standardization with Moderated T. It is observed that B-score
and NPI, combined with the moderated T statistic and the reference value in null hypoth-
esis is 0, produced noisy standardized profile. The between-plate variation exceeds the
between-element variation. Most elements have the average abundance around zero. The
averaged correlations of multivariate phenotype between pairs of plates are only 0.640 and
0.438, which are close to averaged correlations without using any normalization method,
0.558.
However, Fig. 2.5 (b) illustrates that the proposed normalization and estimation pro-
cedure produces the tightest pattern. The averaged correlation is as high as 0.968. The
between-plate variation is much smaller than the between-element variation. This allows
us to obtain repeatable result of detecting changes in element abundance. Supplementary
Materials in [2] provide the other profiles plots for all the controls in the three screens using
different methods.
To quantify the performance of a method, we calculate the averaged Pearson correla-
tions of standardized profiles (as in Fig. 2.5) over plates within a control. Those values are
listed in Table 2.3. Since the proposed approach produces the highest correlation, the noise
is substantially reduced as compared to the other techniques.
Stability of noise reduction to choice of controls. In Table 2.2, the averages of pairwise
Pearson correlations of profiles of the controls in the KO screen quantify the performance
of proposed methods when varying the combination of controls. The averages are between
0.811 and 0.985 that yield consistently high correlations. Therefore, the proposed proce-
dure produces the results with little sensitivity to the specific choice of controls.
Relative contribution of analysis steps to the overall accuracy is shown in Table 2.3.
The average Pearson correlations of the validation controls changed dramatically when the
proposed steps varied in the three screens. Normalization with respect to the covariate and
estimation of residual variance terms (σ2B′ and σ
2
P ′) contribute more to the noise reduction
than the batch- and plate-wise normalization.
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Table 2.2: Averages of Pearson correlations between plates when vary the combinations of
controls for normalization and variance estimation, standardized as in Fig. 2.5(b). Rows:
combinations of controls used for normalization and variance estimation. Columns: the
controls that were not involved in the models
Normalization- Evaluation samples, KO screen













2.5.3 Evaluation based on mutant strains
Since under-estimating the between-plate variation is the main drawback of the exist-
ing procedures, the number of the resulting false positive hits can exceed the nominal FDR.
To illustrate this problem, the moderated T statistics for the KO screen in Table 2.3 were
considered. We fit the two-group model to determine the test statistic cutoff by controlling
FDR not greater than 0.05. The number of mutants with at least one differentially abun-
dant phenotype were determined. Results of such model fit using four existing procedures
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Table 2.3: Pearson correlation of normalized and summarized profiles between plates, for
two positive controls which have not been previously used for normalization or standardiza-
tion. Higher values indicate better noise reduction. ’X’ indicates the applied normalization
and variance estimation steps. The first row corresponds to the proposed approach
Average pairwise Pearson correlation between plates
Normalize: Estimate: (1) KO screen (2) KOd screen (3) OE screen
B, P (B) growth σ2B′ , σ
2
P ′ YLR396C YPR065W YLR396C YPR065W YBR290W YGL008C
X X X 0.968 0.971 0.963 0.940 0.962 0.961
X X 0.904 0.901 0.895 0.869 0.911 0.917
X X 0.777 0.742 0.824 0.783 0.716 0.725
X 0.831 0.797 0.743 0.739 0.705 0.684
X 0.202 0.207 0.176 0.243 0.160 0.292
are illustrated in Fig. 2.6. More results using the other existing procedures are shown in
Supplementary Materials in [2].
The analysis resulted provided in [2] are “3497 (70%) hits using B score; 3709 (75%)
hits using Z score; 4885 (98%) hits using Normalized Percent Inhibition; 4584 (92%)
hits using Plate-wise median; 4044 (81%) hits using Percent of Positive Controls; 3962
(80%) hits using Percent of Negative control; 3359 (68%) hits using Quantile normaliza-
tion. These numbers exceed the 1303 (26%) hits obtained using the proposed procedure,
and likely contain some false positive hits.” Some of these reduction in the number of hits
may lead to a loss of sensitivity. However, the next section illustrates that the proposed
approach is specific, and can help direct the follow-up experiments towards useful targets.
Detection of known changes in abundance. In [41], from the knockout library in yeast,
4358 mutants were assayed. The abundance of 13 elements were quantified. They are Ca,
Co, Cu, Fe, K, Mg, Mn, Ni, P, Se, Na, S, and Zn. Inductively Coupled Plasma-Atomic
Emission Spectroscopy (ICP-AES), was used for the quantification on the ionomic pheno-
types. The instrument is less sensitive and subject to larger variation. Different controls
34























CME: delta: −0.737 sigma: 3.772 p0: 0.984































CME: delta: 0.516 sigma: 4.631 p0: 1.005




 of 4972 mutants




















CME: delta: 0.006 sigma: 5.267 p0: 0.977






















CME: delta: 1.127 sigma: 9.699 p0: 0.967




 of 4972 mutants
Fig. 2.6.: Result of fitting a two-group model by (Efron, 2008) to the test statistics of all
mutants in the KO screen, combined across all the dimensions of the multivariate pheno-
types. The raw phenotypes were normalized as described in legends (a-d), and standardized
with the moderated T statistic. Score cutoffs were chosen to control the False Discovery
Rate at 0.05.
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were used, and no grow rate was adjusted. Given these differences in the experimental set-
tings, 36 (i.e. 65%) of the KO hits reported by that study were confirmed in the list of hits
identified by the proposed approach. Consequently, a sensitive detection of known changes
in the phenotypes is enabled by the proposed noise reduction procedure.
Functional annotation of differentially abundant mutant strains. We further evaluate
the specificity of the proposed approach by considering functional annotations of genes
that statistically changed at least one element abundance. Annotations on those genes were
obtained from the SGD database www.yeastgenome.org, and by literature search. As a
result, 37 hits in the KO screen, and 19 hits in the OE screen, were described as involved
in mineral regulation.
Three of those are YBR290W (BSD2∆), YGL167C (PMR1∆) and YPR194C (OPT2∆).
They were found as differentially changing the abundance of Cadmium (Cd) in the KO
screen. The same conclusion on the involvement of these genes in Cadmium regulation has
been previously established. In particular, endoplasmatic reticulum (ER)-localized mem-
brane protein is encoded by BSD2 (bypass SOD deficiency). The protein controls the
uptake of divalent metal ions from the growth medium [42]. Furthermore, the major Golgi
membrane-localized Ca2+ and Mn2+-transporting P-type ATPase is PMR1. It is essential
for intracellular Cd2+ trafficking and detoxification [43, 44]. Finally, As an oligopeptide
transporter, cells’ sensitivities to anticancer drugs and divalent ion Cd can be increased by
the loss-of-function of OPT2 [45].
Experimental validation. We also experimentally validated 19 KO mutant strains, which
were determined as differentially abundant in Cd using the proposed design and analy-
sis methods. S. cerevisiae cells in the validation experiment were grown overnight to an
OD600 nm of 1.3. “Aliquots of the cell suspensions were then serially diluted 10-, 100-
and 1000-fold and spotted onto solid YNB medium supplemented with the indicated con-

















































































Fig. 2.7.: Cadmium sensitivity of BY4741 wild type (Wt) and selected mutant strains. (a)
YBR290W (BSD2∆) and YGL167C (PMR1∆) to Cd supplement in growth medium.
(b) YPR194C (OPT2∆).
The growth of three mutant strains among the 19 profiled mutants, YBR290W (BSD2∆),
YGL167C (PMR1∆) and YPR194C (OPT2∆) were compared to the wild-type BY4741
strain in the medium with or without Cd. Pictures of experimental results are shown in
Fig. 2.7.
On the medium without Cd, the growth of the three KO strains is indistinguishable
from the control strain. On medium supplemented with Cd, all the three KO strains are
more sensitive to Cd than control strain. The sensitivity increased after Cd concentration
was increased. In this validation experiment, we obtained the results that are consistent
with the KO ionomic screen with the proposed methods. It was concluded that these lines
accumulate more Cd than the majority of mutants. The direction of changing Cd abundance
is also consistent with the existing literature. Evidence has been established for the role
of BSD2, PMR1 and OPT2 in Cd detoxification [42, 43, 45]. We also obtained similar
experimental confirmation for 18 out of the 19 mutant strains identified in the KO screen.
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2.5.4 Extension results of biological conclusion
In a downstream research based on the results of the proposed methods, we further
obtain meaningful biological conclusion in [3]. There are 1065 mutant strains finally iden-
tified with changes in element abundance. They are 584 mutant strains in KO screen, 35
mutant strains in KOd screens, and 446 mutant strains in OE screens. Using hierarchical
clustering method, we identify important grouped roles for the mitochondria, vacuole and
ESCRT pathway that regularize the ionome. Using network analysis, we detect hub genes
such as PMR1 in Mn homeostasis. Combining the information curated by BioGrid [46],
we identify novel members of ionomic networks such as SMF3 in vacuolar retrieval of Mn.
All yeast ionomic data can be downloaded at www.ionomicshub.org.
2.6 Conclusion
Accurate interpretation of true biological phenotypes based on high-throughput pertur-
bation screens is challenging due to restrictions on their experimental design and imple-
mentation. For example a plate can only have small number of samples, small number of
replicates for each mutant have to be nested within plates, and then few or no mutant repli-
cation between plates. Consequently, effects due to plates, plates nested in batches, and
confounding variable (i.e. growth rate) can dominate variation in scored phenotype.
In this work, we proposed an experimental design that requires at least two control sam-
ples. One is used for normalization and the rest are used for variance estimation based on
linear mixed-effects models. We observed that control samples are less affected by outly-
ing phenotype than mutant samples especially for the screens where a large proportion of
samples show changes in the phenotypes. Motivated by this insight, we focused on control-
based normalization, and substantially reduce those sources of artificial variation. We fur-
ther account for the stochastic variation due to the interaction between plates and mutant
samples. This step of estimating residual non-additive effects is important for the optimal
detection of hits. By evaluating several existing procedures and the proposed procedures
based on three perturbation screens profiling elements abundance, we illustrated in [2] that
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“the proposed methods can obtain comparable scores used in conjunction with a practical
experimental design, allows extensions to alternative structures of data, enables a specific
discovery of biologically meaningful hits, strongly outperforms the existing approaches".
Therefore this proposed procedures are recommended as a useful tool in high-throughput




1 Whole transcriptome shotgun sequencing (RNA-seq) technology [47–49] quantifies
gene expression in biological samples in counts of transcript reads mapped to the genes.
Accurate and comprehensive, it has made a major impact on genomic research [50–52].
One common goal of RNA-seq experiments is to detect differentially expressed genes, i.e.
genes for which the counts of reads change between conditions more systematically than as
expected by random chance [51]. Statistical methods for detecting differentially expressed
genes must reflect the experimental design, and appropriately account for the stochastic
variation. Moreover, many RNA-seq experiments serve as high-throughput screens of a
small number of samples with the goal of subsequent experimental validation. Therefore
the analysis must handle a relatively small number of biological replicates.
A variety of statistical methods and software has recently been proposed for detecting
differentially expressed genes. These include DESeq [53], edgeR [54, 55], baySeq [56],
SAMseq [57], BBSeq [58]. We briefly overview these methods. We further propose a di-
rect and effective approach for characterizing the variation in the counts of reads, which
improves the sensitivity and specificity of detecting differentially expressed genes for ex-
periments with small sample size. We support this approach with an open-source R-based
software package sSeq.
1Copy rights are released with Publisher’s permission.
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3.2 Background
3.2.1 The Negative Binomial distribution
The input to the statistical analysis is a set of discrete counts of reads in each experimen-
tal run. Although the counts can be modeled with the one-parameter Poisson or Geometric
distributions [59–61], it is often advantageous to use the two-parameter Negative Binomial
distribution [53–56]. This distribution is more general and flexible, and can be viewed as a
generalization of both Poisson and Geometric distributions.
A Negative Binomial random variableX ∼ NB(p, r) counts the number of failures be-
fore the rth success in a series of independent and identical Bernouilli trials with probability
of success p. Its probability distribution is
P{X = x | p, r} =
 r + x− 1
x
 (1− p)xpr for integer x ≥ 0 and p ∈ (0, 1), (3.1)
E{X} = r1− p
p
, and V ar{X} = r1− p
p2
An alternative parametrization used in this manuscript is X ∼ NB(µ, φ) such that
P{X = x | µ, φ} =

























Sum of Negative Binomial random variables is also Negative binomial random variable,
that is, ifXj ∼ NB(p, rj), j = 1, . . . , n and are independent, then
∑n
j=1 Xj ∼ NB(p,
∑n
j=1 rj).
There are several connections to the Negative Binomial distribution and the other dis-
tributions. Firstly, it generalizes the Poisson distribution for count data. If we assume that
X ∼ Poisson(λ), and the expected value of the Poisson distribution is itself a random
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variable λ ∼ Gamma(φ−1, µφ), µgi, φgi > 0, then the marginal distribution of X (on
average over all possible expected values λ) is
P{X = x | µ, φ} =
∫ ∞
0





























This connection motivates the use of the Negative Binomial distribution in RNA-seq exper-
iments. Marioni et al. [61] demonstrated that the Poisson distribution adequately represents
the technical variation of the counts in replicated libraries of a same biological sample. The
Negative Binomial distribution allows us to explicitly model the combined effect of the bi-
ological and technical variation, as it inflates the total variation beyond what is specified by
the Poisson distribution.
The Poisson-Gamma model is not the only motivation for modeling counts of RNA-
seq reads with the Negative Binomial distribution. The Negative Binomial distribution
can also arise as the sum of Geometric distributions, i.e. if Xj
iid∼ Geometric([1 +
(µφ)−1]−1), j = 1, . . . , φ−1, then
∑φ−1
j=1 Xj ∼ NB(µ, φ). Alternatively, the Negative
















We focus on the Negative Binomial distribution in what follows. Denote Xgij as the
random variable that expresses the counts of reads mapped to gene g (g = 1, . . . , G) in
sample (or, equivalently, library) j (j = 1, . . . , ni) in condition i, and denote xgij as the
observed values. For simplicity we consider two conditions (i = A,B), however the dis-
cussion holds for pairwise comparisons of conditions in experiments with more complex
designs. We are particularly interested in situations where nA and nB are small, e.g. 1-4.
We consider the following parametrization:
Xgij ∼ NB(µgi, φg), where µgi ≥ 0, φg ≥ 0, such that




The dispersion parameter φg determines the extent to which the variance Vgi exceeds the
expected value µgi [62, 63].
3.2.2 Motivation for the proposed approach
The estimation of Var{Xgij} is the main focus of this work, and is based on the follow-
ing considerations.
1. A naïve approach is to estimate Var{Xgij} using the method of moments (i.e. the
per-gene sample variance). However it is highly variable in experiments with a small
sample size [64].
2. RNA-seq experiments simultaneously quantify the expression of many genes. The
genes share aspects of biological and technical variation, and therefore a combination
of the gene-specific estimates and of consensus estimates can yield better estimates
of variation. Such approaches are increasingly popular with RNA-seq experiments
[53, 55].
3. The variance of the Negative Binomial distribution is a known function of the ex-
pected value µgi and of the dispersion φg, where φg is gene-specific. Therefore an
accurate estimation of the dispersion (e.g. by combining the gene-specific and con-
sensus estimates, without explicitly modeling its relationship to µgi) can lead to an
accurate estimation of the variance, while preserving the mean-variance relationship.
4. Finally, constraints of throughput, sample availability or cost may restrict the number
of biological replicates. Although experiments with little or no biological replication
have poor reproducibility and are undesirable, such under-replicated screens are the
only practical option in some situations [65, 66]. They can only detect large changes
in expression, and require an extensive downstream validation with complementary
low-throughput experiments and large sample size. To detect differentially expressed
genes in such screens we assume that the majority of the genes are not differentially
expressed, and that for these genes the samples from all conditions can be viewed as
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biological replicates [54, 67]. Under this assumption a consensus estimate of disper-
sion can help us to improve the accuracy of gene-specific estimates of variation.
Our main concern is in how to (1) accurately define the consensus estimate of dispersion,
and (2) accurately combine the gene-specific estimates of dispersion with the consensus
estimate.
3.2.3 Existing approaches for RNA-seq experiments
Among the existing methods, edgeR [54, 55], DESeq [53] and baySeq [56] assume
the Negative Binomial distribution, and SAMseq [57] and BBSeq [58] utilize other flexi-
ble models. The approaches have been extensively evaluated [68], and are broadly used.
Hardcastle and Kelly [56] found that the performance of DESeq, edgeR and baySeq is su-
perior to that of DEGseq [69], Li and Tibshirani [60] found that SAMseq improves upon
PoissonSeq [60]. We briefly overview these approaches in the historical order. Table 3.1
summarizes the discussion.
Probability model. edgeR models the count of reads with the Negative Binomial distri-
bution. It includes normalization, which accounts for the changes in read counts due to
technical artifacts such as different sequencing depth. The normalization factor can be the
total library size (i.e. the number of reads in the library). A more accurate normalization
factor is the ‘effective’ library size mij , which multiplies the size of the library ij by a
robust estimate of the log-fold change of the total count in condition i as compared to a
reference run [67]. The parameter pgi in row (b) of Table 3.1 is the probability that a single
read maps to gene g for a sample in condition i. The model assumes that the dispersion
parameter is gene-specific, but constant across conditions. For experiments without repli-
cation versions up to 2.4.6 assumed a common dispersion in all the genes. The subsequent
versions discourage unreplicated experiments. Finally, alternatives based on generalized























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DESeq also models the count of reads with the Negative Binomial distribution. It nor-










The size factor can be thought of as the ‘representative’ ratio of counts in the library to the
geometric mean of the counts in all the libraries, and differs from the ‘effective’ library size
in edgeR. The parameter µgi in row (c) of Table 3.1 is the expected normalized expression
of gene g in condition i. DESeq allows specification of separate variances for genes and
conditions, and models the variances as functions of the expected values. This relationship
can be a flexible smooth function (local polynomial) or a parabolic function V̂gi = sij ·µ̂gi+
s2ij · µ2gi · (a0 + a1/µ̂gi), where a0, a1 > 0 are constants. Alternatives based on generalized
linear models for the Negative Binomial response are also available.
baySeq specifies the same probability model as edgeR, however it proposes a different
Empirical Bayes characterization of the between-library variation. baySeq assumes that
subsets of the libraries share the parameters of Negative Binomial distribution, and derives
an empirical prior distribution for the corresponding parameter sets. After integrating over
the empirical priors, the dispersion in the integrated likelihood is constant across conditions
and different between the genes. The default normalization parameter is the library size.
BBSeq specifies a Beta-Binomial generalized linear model. Using the logit link, the
model connects the expected probability of a read for gene g in condition i and sample j to
the linear combinations of predictors, such as indicators of conditions and other covariates.
The dispersion parameter can be independent from the mean (free model), or dependent on
the mean (constrained model). Finally, SAMseq utilizes a fully non-parametric approach.
Estimation of dispersion. edgeR maximizes a weighted combination of the conditional
log-likelihoods with per-gene dispersion and of the conditional log-likelihood with com-
mon dispersion. Conditional likelihoods generalize the restricted maximum likelihood
(REML) estimation for a discrete response by conditioning on the sum of the read counts
per class, and improve the statistical properties of dispersion estimates. The estimation
requires calculating pseudocounts of reads that would have been obtained with libraries of
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equal size, and an iterative computational optimization. For experiments with few repli-
cates the estimates tend to be discrete values [70–72]. For experiments with many repli-
cates, edgeR specifies a generalized linear model. Since conditional likelihoods cannot
be easily extended to this case, these are further approximated by adjusted profile likeli-
hoods [73].
DESeq starts by estimating per-gene means and variances of the normalized counts in
each gene and condition by the methods of moments. Next, it re-estimates them by fitting
the postulated relationship between the expected values and the variances. The estimates
of dispersion can be back-calculated from the estimates of variance as shown in row (c)
of Table 3.1. For experiments without replication, DESeq assumes that the majority of
the genes are not differentially expressed, and combines the samples across conditions to
estimate the variance. The same strategy is used with the generalized linear models.
baySeq relies on an iterative estimation of the relative gene expression and of the dis-
persion. Given an initial partition of the libraries into subsets and an initial estimate of the
relative gene expression, it estimates the dispersion using the quasi-likelihood approach.
Given the estimates of dispersion, it re-estimates the relative gene expression by maximiz-
ing the integrated likelihood. This is repeated for different partitions of the libraries into
subsets.
BBSeq estimates the dispersion using maximum likelihood for the free model. For
the constrained model it uses the estimates from the free model for all the genes, fits the
postulated relationship to the mean, and re-estimates the dispersions. SAMseq side-steps
the need to estimate the dispersion by using a fully non-parametric approach.
Testing. For the Negative Binomial model, edgeR tests the null hypothesis H0 : pgA =
pgB, and DESeq H0 : µgA = µgB separately for each gene. Both edgeR and DESeq utilize
the exact test, which is free from asymptotic arguments and is therefore preferred. The test
statistic for a gene is the total (normalized) count of reads in all the replicates of a condition.
The p-value is the probability of the normalized read counts per group, such that under H0
their probability is same or lower than the probability of the observed counts, conditional
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on the total counts equal to the observed. With the generalized linear models, edgeR and
DESeq use the asymptotic likelihood ratio or Wald tests.
baySeq ranks the genes according to their posterior probabilities of differential expres-
sion. BBSeq tests the coefficient of the linear predictor (i.e. condition) in the generalized
linear model with the asymptotic Wald test. SAMseq utilizes a resampling strategy to esti-
mate the distribution of the test statistic and the p-values.
3.3 Methods
The proposed approach combines aspects of the existing approaches, but is simpler,
requires fewer assumptions and streamlines the computation. It is summarized in Ta-
ble 3.1(a).
3.3.1 Probability model
Denote Xgij the counts of reads of gene g = 1, . . . , G, replicate j = 1, . . . , ni and
condition i = A,B. Denote sij the size factor of the replicate j in the condition i. The
probability model is
Xgij ∼ NB(µgi sij, φg/sij), where µgi ≥ 0, φg ≥ 0, sij > 0 such that (3.7)







This model is one way to represent RNA-seq experiments, however it is quite flexible.
First, the free per-gene dispersion parameter φg accommodates arbitrary dependencies of
dispersion on the expected value, and is particularly useful in experiments with a small
sample size where the true relationship may be obscured by the noise.
Second, the assumption regarding the size factors can be meaningful from the experi-
mental viewpoint, and also for technical modeling reasons. From the experimental view-
point, Eq. (3.8) shows that size factors sij linearly scale both the expected value of the
counts of reads and their variance. Since the differences in library size are technical arti-
facts, and since the technical variation in RNA-seq experiments can be characterized with
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the Poisson distribution, the linear scaling of the variance with the library size is consistent
with the Poisson2. Moreover, this assumption enables us to use the Negative Binomial dis-
tribution to directly model both the counts of reads in one replicate library (necessary to
introduce the size factors), and the sum of the counts in the replicate libraries of a condition
(necessary to conduct the exact test). As detailed in Appendices, a traditional interpretation
of a Negative Binomial random variable is ‘the number of failures before the rth success in
Bernouilli trials with probability of success p’. In this traditional parametrization






Introducing the size factor as in Eq. (3.8) implies a constant p, i.e.
pgi =
1








Therefore, the size factors can be interpreted as scaling the required number of successes














j=1 sij, V ar{
∑ni
j=1 Xgij} = µgi
∑ni





We follow edgeR, DESeq and baySeq by specifying a Negative Binomial distribution.
Since in experiments with a small sample size it may be difficult to distinguish the true
dependency of dispersions on expected values from artifacts of random variation, the model
specifies free gene-specific dispersion parameters φg. As the initial versions of edgeR we
specify a common dispersion across conditions, i.e. φgA=φgB
denoted
= φg. As a consequence,
the counts of differentially expressed genes have different variances in each condition.
We follow DESeq in normalizing the counts by the size factor sij . However in the
proposed normalization the size factor affects not only the expected value, but also the
dispersion. Eq. (3.8) shows that under this assumption the size factor linearly scales both
E{Xgij} and Var{Xgij}. Such linear scaling is consistent with the technical variation in
2Alternative models of the scaling factors, such asXgij ∼ NB(µgi sij , φg), assume extra-Possion scaling of
the variance, i.e. Var{Xgij} = µgi sij + µ2giφg s2ij . In experiments with small sample size it may be difficult
to evaluate which model fits best, and the two approaches are similar when the size factors are close to 1.
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RNA-seq experiments, which can be characterized by the Poisson distribution [61]. Since
typical size factors are close to 1, the proposed model has little practical difference from
the model in DESeq. However, as shown in Chapter 3.3.4, it allows us to directly conduct
the exact test and contributes to the accuracy of the results.
3.3.2 Estimation of dispersion
Similarly to DESeq, we start by estimating the dispersion parameters by the methods
of moments. A conservative estimate of the per-gene variance in experiments with a small
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and g = 1, . . . , G. The estimate of dispersion φ̂MMg is then calculated from Eq. (3.5), and





















Unfortunately, in experiments with small sample size φ̂MMg are unsatisfactory due to high
variance [74–76]. Next we improve the statistical properties of these estimates by intro-
ducing shrinkage.
Stein [77] showed that when we estimate the expected values of three or more indepen-
dent Normal random variables with known constant variance, shrinking the per-dimension
estimates toward a target value ξ produces biased estimates, but reduces the mean squared
error (MSE) for all choices of ξ. The shrinkage estimator by James and Stein [78–80] im-
plements this strategy. More recently Hansen extended the approach of James and Stein
with a generalized shrinkage estimator, [81]. Hansen’s shrinkage can be used with any
per-dimension estimator with an arbitrary sampling distribution (not necessarily Normal),
for which the Central Limit Theorem holds. Specifically, it requires that the true parameter
lies in a neighborhood of the restricted parameter space, and that the estimator is asymp-
totically Normal with a consistent variance. Estimators by the method of moments satisfy
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these criteria. Applied to the estimation of φg, and assuming that the per-gene estimates are
independent, the generalized shrinkage estimator is
φ̂sSeqg = (1− δ)φ̂MMg + δ · ξ = ξ + (1− δ) (φ̂MMg − ξ) (3.13)
As can be seen, φ̂sSeqg is a linear combination of the pre-defined target ξ and of the per-gene












g − ξ)2/(G− 2)


















g − ξ)2, the weight δ ∈ (0, 1). Larger values of δ
shrink the estimates closer to the pre-defined target ξ.
We utilize the Hansen’s generalized shrinkage estimator φ̂sSeqg in conjunction with the
Negative Binomial distribution to test genes for differential expression. Although the as-
sumption of φ̂MMg being independent variables is simplistic, it is a suitable approximation
for experiments with a small sample size. A similar assumption is made, e.g. by DESeq
when modeling the variance as function of the mean. While the asymptotic argument can-
not be justified in this context, we show empirically in Chapter 3.5 that φ̂sSeqg performs quite
well in practice.
Hansen showed that the estimator in Eq. (3.13)-Eq. (3.14) reduces the asymptotic MSE
for all choices of targets ξ. However a good practice is to select a value for ξ that maximizes
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g − φ̂MMg )2 (3.15)
Eq. (3.15) substitutes φg with φ̂MMg , and divides MSE by the constant G for numeric sta-






Fig. 3.2(a) visualizes the functional form of ASD(ξ) for a simulation in Chapter 3.4, and
shows that the tail of the curve flattens for large ξ. Therefore we can also minimize the
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bias by minimizing ξ, while enforcing the constraint that ASD(ξ) is comparably small. In
practice sSeq estimates ξ̂ by calculating the slope of ASD(ξ), and setting
ξ̂ = argminξ {−ε < slope(ASD(ξ)) < 0} (3.17)
for a small constant ε such as ε = 0.05. The selected value is shown by the vertical line in
Fig. 3.2(a).
Fig. 3.2(b) illustrates the fact that the proposed shrinkage estimator is a linear transfor-
mation of φ̂MMg . The slope of the transformation is (1 − δ) ∈ (0, 1), and the fixed point is
the shrinkage target ξ. The shrinkage increases the per-gene estimates of dispersion that are
smaller than ξ, and decreases the values that are larger than ξ. From our experience with
multiple datasets, ξ̂ is often around the 97.5th quantile of φ̂MMg . In other words, it biases
the majority of the estimates towards larger (and more conservative) values.
The proposed estimate of dispersion has analogies in methods developed for other high-
throughput technologies. For example, it is similar in spirit to the moderated variance
estimator in the package Limma [82, 83], which is also a linear combination of per-gene
and consensus estimates.
3.3.3 Exact test for a two-group comparison
We follow edgeR and DESeq by testing H0 : µgA = µgB per gene with the exact
test. The test statistic is Xgi·, i.e. the sum of the read counts in each condition, XgA· =∑nA
j=1 Xgij and XgB· =
∑nB
j′=1Xgij′ . According to Eq. (3.10),
XgA· ∼ NB(sA · µgA, φg/sA), and XgB· ∼ NB(sB · µgB, φg/sB) (3.18)
where sA =
∑nA
j=1 sAj and sB =
∑nB
j=1 sBj . Under H0,
XgA·
H0∼ NB(sA · µg, φg/sA), and XgB·
H0∼ NB(sB · µg, φg/sB) (3.19)
Since the counts from the two conditions are independent, the joint probability distribution
of (XgA·, XgB·) is
P{XgA· = xgA·, XgB· = xgB·|H0} = P{XgA· = xgA·|H0} · P{XgB· = xgB·|H0} (3.20)
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The p-value of the exact test is the combined probability of all the read counts per group,
such that under H0 they have a same or a lower probability than the counts observed,
conditional on the total counts equal to the observed. Mathematically,









P{XgA· = xgA·|H0} · P{XgB· = xgB·|H0}
set1 = {XgA·, XgB· | XgA· +XgB· = xgA· + xgB·}
set2 = {XgA·, XgB· | XgA· +XgB· = xgA· + xgB· ∩ (3.22)
P{XgA·, XgB·} ≤ P{xgA·, xgB·}} (3.23)
In practice the probabilities in Eq. (3.21) are calculated by substituting µ̂g, φ̂sSeqg , ŝA =∑nA
j=1 ŝAj and ŝB =
∑nB
j=1 ŝBj into the probability distributions in Eq. (3.19). The p-values
are adjusted by method such as in [84] to control the False Discovery Rate.
3.3.4 Exact test for complex experiments
We consider two types of experimental designs that are more complex than a two-group
comparison, and focus on pairwise comparisons of conditions.
Factorial experiments: The experiment in Hammer et al. [85] had a factorial design. It
considered two factors (rat strains Sprague Dawley and L5 SNL Sprague Dawley 2, and
time points 2 weeks and 2 months), and considered distinct biological replicates for each
combination of strain and time.
Pairwise comparisons of conditions in such experiments is straightforward. We created
a new condition with fours levels (Sprague Dawley, 2 weeks; Sprague Dawley, 2 months;
L5 SNL Sprague Dawley 2, 2 weeks’ L5 SNL Sprague Dawley 2, 2 months). The null
hypotheses comparing pairs of conditions H0 : µgi = µgi′ , i, i′ ∈ {1, 2, 3, 4}, i 6= i′, were
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then tested as in Chapter 3.3.3, while the dispersion parameter were estimated using read
counts from all the conditions.
Repeated measurements: The experiment in Tuch et al. [86] had a paired design, in that
pairs of normal and tumor samples were obtained from each of the three patients. This is
a special case of the repeated measurements design. The design is advantageous because
it eliminates the between-subject biological variation from consideration when comparing
the conditions.
To analyze such experiments we propose to view each subject as a separate independent
unreplicated experiment. Since sSeq can handle unreplicated experiments, we derived the
estimates of dispersion φ̂sSeqg separately for each subject, thus reflecting the within-subject
variation. Next we tested H0 separately for each subject, obtaining separate p-values for
each subject and each gene. Finally, assuming that the subjects are independent, we com-
bined the p-values for each gene using Fisher’s method [87] and obtained the consensus
p-values.
There are at least two ways to obtain φ̂sSeqg . The first is to shrink the method of moment
estimates φ̂MMjg separately for each subject across conditions. The second is to average
the per-subject method of moments estimates φ̂MMjg , and proceed with a single shrinkage
step of the averaged estimates. We compared the sensitivity of these two approach for the
Tuch dataset (detailed in Chapter 3.4). Fig. 3.1 shows that shrinking averaged estimates
of dispersions resulted in a higher sensitivity. At the same time, both approaches are less
sensitive than the analysis that ignores the paired nature of the design. The loss of sensi-
tivity is possibly due to inefficiencies of the Fisher’s methods, and several alternatives can
potentially be considered [87].
Fig. 3.3 in the main manuscript is based on the shrinkage of the averaged method of
moment estimates. The figure shows that despite the loss of efficiency the method has a












Fig. 3.1.: The number of differentially expressed genes in the Tuch dataset with paired
experimental design. ‘perPairDisp’: separate dispersion estimation and shrinkage for each
subject. ‘poolDisp’: averaged per-subject method of moments estimates of dispersion, and
a single shrinkage step of the averaged estimates. ‘factor2’: analysis that ignores the paired
nature of the design, and treats it as a two-group factorial experiment.
3.4 Datasets
We evaluated the proposed approach using ten simulated and experimental datasets.
The first five datasets had an external ‘gold standard’ of differential expression, and the last
two had experimental designs more complex than a two-group comparison. Simulation1,
Simulation2 and Simulation3 each generated G=20,000 genes in conditions A and B,
nA = nB = 2. Parameters µgA and φg were simulation-specific (see below). 30% of the
genes were simulated as differentially expressed, and for these genes µgB = µg/exp(ε)
where ε iid∼ N (0.5, 0.252). Size factors were sampled from the Uniform distribution sij ∼
Uniform(0.5, 1.7), and rounded to the first decimal place. The simulated size factors are
reported in Chapter 3.5.4. Read counts for gene g in sample j (j=1, 2) and condition i



































































































































































































































































































































































































































































































Simulation1 The expected values are randomly sampled from µg ∼ Exponential(λ =
250), where λ is the expected value. The dispersion parameter is considered as a constant
across genes, φg = 0.1.
Simulation2 As above, the expected values are randomly sampled from µg ∼ Exponential
(λ = 250), where λ is the expected value. The dispersion parameters are functions of the
expected values φg = 1/(100 + µg). This setting is the same as in [53].
Simulation3 From the dataset by Bottomly et al [88,89], the largest experimental dataset
in this manuscript, we selected a subset of non-differentially expressed genes (as deter-
mined by a consensus of sSeq, edgeR and DESeq), and sampled pairs (µ̂MMgA , φ̂
MM
g ) from
this subset as the true parameters.
MAQC [90] is the dataset from the MicroArray Quality Control (MAQC) consortium,
comparing three libraries from Ambion human brain reference RNA against two libraries
from Stratagene human universal reference RNA. The libraries were sequenced with the
Illumina platform, resulting in 19,580 genes. The read counts for the RNA-Seq experiment
were downloaded from http://www.ncbi.nlm.nih.gov, accession number SRA010153. The
human genome hg19 was downloaded from http://genome.ucsc.edu. The reads from each
library were mapped to the human genome using Bowtie [91] command bowtie -q -v
2 -a -m 1 -p 8 -quiet hg19 input.fastq output.map.
A subset of the genes from four of the libraries were assayed by real-time reverse-
transcription PCR (qRT-PCR) [90, 92]. To obtain the external ‘gold standard’ of differ-
ential expression, the qRT-PCR quantifications were downloaded from Gene Expression
Omnibus (GEO, accession GSE5350). We compared the quantifications in the two condi-
tions with the t-test. A gene was termed as differentially expressed if its p-value was less
than 0.00001 (statistical significance), and the absolute fold change exceeded 2.1 (practical
significance). A gene was termed non-differentially expressed if its p-value exceeded 0.2
(statistical significance), and absolute fold change was less than 1.5 (practical significance).
This produced 323 differential genes and 85 non-differentially expressed genes. We used
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the 323 differential genes and 85 non-differentially expressed genes determined by qRT-
PCR as the ‘gold standard’. Although the dataset only has technical replicates, it has been
used extensively as the benchmark in the past [93–95].
Griffith et al. [96] compared fluorouracil (5-FU)-resistant human colorectal cancer cell
lines MIP101 against their nonresistant counterpart MIP/5-FU24. The counts of aligned
RNA-seq reads were downloaded from GEO (accession GSE23776). One library from each
condition was quantified with the paired-end Illumina platform, resulting in 27,145 genes.
197 of these genes from the same samples were assayed by quantitative PCR (qPCR).
The qPCR data were downloaded from http://www.alexaplatform.org/alexa_seq/index.htm.
As above, we compared the conditions with the t-test. For this dataset a gene was con-
sidered as truly differentially expressed if its p-value was less than 0.00001 (statistical
significance) and the absolute fold change exceeded 3 (practical significance), and truly
non-differentially expressed if its p-value exceeded 0.2 (statistical significance) and abso-
lute fold change was less than 0.9 (practical significance). This produced 12 differentially
expressed genes and 19 non-differentially expressed genes. We used 12 truly differential
genes and 19 truly non-differentially expressed genes as determined by qPCR as the ‘gold
standard’ for method comparison.
Brooks et al. [97] compared untreated cells of Drosophila melanogaster against cells cul-
tured in presence of Pasilla, the homologue of the mammalian Nova-1 and Nova-2 protein.
The table of read counts was downloaded from the R package pasilla published at Biocon-
ductor. Two biological samples per condition were sequenced with the paired-end Illumina
platform, resulting in 14,470 genes.
Sultan et al. [89, 98] compared two biological replicates of human cell lines Ramos B and
HEK293T with the Illumina platform, yielding 6,573,643 uniquely aligned reads.
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Bottomly et al. [88, 89] compared brain tissues of two inbred mouse strains, C57BL/6J
(B6) and DBA/2J (D2), using the Illumina platform. The analysis of 10 and 11 biological
samples per condition resulted in 343,445,340 uniquely aligned reads.
Hammer et al. [85, 89] compared gene expression in rat strains Sprague Dawley and L5
SNL Sprague Dawley 2, at two times (2 weeks and 2 months) in a factorial design. Two dis-
tinct biological libraries per condition and per time slot were quantified using the Illumina
platform, resulting in 158,178,477 uniquely aligned reads.
Sultan, Bottomly and Hammer The read counts for these dataset were downloaded
from http://bowtie-bio.sourceforge.net/recount [89].
Tuch et al. [86] compared the expression of genes in normal human tissues and in tissues
with oral squamous cell carcinoma. The table of read counts was downloaded from GEO
(accession GSE20116). The experiment had a paired design in that pairs of normal and
tumor samples were obtained from three patient. The six libraries were sequenced using
the SOLiD platform, resulting in 10,453 genes.
3.5 Results
We compared the performance of sSeq to the existing approaches. The following ver-
sions of the existing packages were used: edgeR v3.0.8 (January 2013), DESeq v1.10.1
(October 2012), baySeq v1.12.0 (October 2012), BBSeq v1.0 (March 2011), SAMSeq as
part of the R package samr v2.0 (June 2011).
For sSeq, all the datasets were analyzed with the exact test, and analyses of the Hammer
and the Tuch datasets accounted for their experimental designs. For edgeR and DESeq,
the datasets with two-group comparisons were analyzed with the exact test, and Ham-
mer and Tuch datasets were analyzed with the glm-based approaches. For edgeR, the























































































































































































































































































































































































































































· · · nA=nB=1
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· · · nA=nB=1







· · · nA=nB=1
– · – Full dataset
p-value p-value p-value 1-post. prob. p-value
Fig. 3.3.: The empirical cumulative distribution function (ECDF) curves of detecting dif-
ferential expression for the datasets with no external ‘gold standard’. Y-axis: ECDF, func-
tion of the gene rank. X-axis: p-value or 1 minus posterior probability. Solid line: two
randomly selected replicates from a same condition (AvsA). Dotted line: one randomly
selected replicate from each condition (unreplicated AvsB). Dashed line: AvsB on the
full dataset for two-group designs. Dashed-dotted line: AvsB on the full dataset for more
complex designs. Gray line: 45 degree. SAMseq is not applicable to unreplicated exper-
iments and is excluded. The desired patterns are high areas under the AvsB curves, and
AvsA curves that are at or below the 45 degree line.
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used to analyze un-replicated datasets. For DESeq, the option fitType="local" was
used to estimate the per-group variance. The default parameters were used otherwise.
3.5.1 sSeq accurately estimates the variation
Since the proposed approach shares most similarities with edgeR and DESeq, we com-
pared their estimates of dispersions and variances in more details. Fig. 3.2(c), (e) and (g)
use the simplest case of Simulation1 to illustrate the estimates by the method of moments
and by the three approaches. As expected, φ̂MMg have a high variance, which increases with
the mean. Also as expected, estimates by φ̂sSeqg are biased towards larger values but have
smaller deviations from the true values as compared to φ̂MMg . Estimates by the other two
methods fit the pattern of φ̂MMg .
Fig. 3.2(d), (f) and (h) show that despite the differences in dispersion estimation, the
estimates of variance by the three methods are less different. This is due to the fact that
the values of the dispersions are small as compared to the means, and that the variances
in Eq. (3.5) are highly influenced by the expected values. As the result, the bias in the
estimation of the dispersion has a low impact on the overall estimation of variation. Similar
plots for the other datasets are provided in Supplementary Materials of [4].
The first two columns of Table 3.2 show that the bias also has little impact on the
performance of detecting differentially expressed genes, as the performance of sSeq, edgeR
and DESeq are relatively similar. sSeq has a slightly higher area under the ROC curves.
Fig. 3.2(d), (f) and (h) also provide an insight into why shrinking the method of mo-
ments estimates of dispersion is more beneficial than shrinking the method of moments
estimates of variance. The figures show that on the log scale the relationship between the
mean and the variance in the Negative Binomial distribution is roughly linear for large
mean counts. Mathematically, from Eq. (3.5)
log(Vgi) = log(µgi + µ
2
giφg) = log(µgi)+log(µgiφg + 1)
log(Vgi)
large µgi
≈ 2 · log(µgi) + log(φg) (3.24)
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A shrinkage of the variance estimates would multiply them by (1 − δ) ≤ 1, and would
distort the slope of the mean-variance relationship in Eq. (3.5) away from 2. The shrinkage
of the dispersion parameter, on the other hand, preserves this nominal mean-variance rela-
tionship. Our results (shown in Supplementary Materials of [4]) confirmed that shrinking
the variance leads to inferior performance.
To further investigate the usefulness of multiple shrinkage targets, we partitioned the
genes into 10 groups according to the ranges of µ̂MMg , and applied the shrinkage sepa-
rately to each group. Our results (not shown here) indicated that there is no advantage in
specifying multiple shrinkage targets.
3.5.2 sSeq accurately detects differential expression
Five datasets with an external ‘gold standard’ were used to evaluate the sensitivity and
the specificity of detecting differentially expressed genes. For each method the genes were
ranked by FDR-adjusted p-value of posterior probability, and termed ’significant’ for vary-
ing cutoffs. The sensitivity and the specificity of differential expression was compared to
the ‘gold standard’, and summarized with Receiver Operating Characteristic (ROC) curves.
Table 3.2 shows that the proposed approach consistently had a similar or a higher accuracy
as compared to the existing methods.
Five datasets without an external ‘gold standard’ were used to evaluate the sensitivity
and the specificity less formally, as discussed in [53]. First, comparisons of two conditions
(‘AvsB’) had some truly differentially expressed genes. Therefore methods with higher
sensitivity should have higher areas under the empirical cumulative distribution functions





≤p}. Second, comparisons of
replicates of a same condition (‘AvsA’) had no differentially expressed genes. Therefore
methods with higher specificity should have ECDF curves at or below the 45 degree line.
For baySeq we expect similar patterns of the ECDF curves based on the posterior probabil-
ity cutoff. Fig. 3.3 summarizes the curves for the five datasets. It shows that sSeq produced
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Simulation1, nA=nB=1 Simulation1, nA=nB=2
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Simulation3, nA=nB=1 Simulation3, nA=nB=2

















































Fig. 3.4.: Areas under the ROC curves of detecting differentially expressed genes for the
simulated datasets in Table 3.2.
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MAQC project, nA=nB=1 MAQC project, nA=3, nB=2

















































Griffith et al., nA=nB=1
























Fig. 3.5.: Areas under the ROC curves of detecting differentially expressed genes for the
experimental datasets with an external ‘gold standard’ in Table 3.2.
65
Table 3.3: Areas under the ROC curves of detecting differentially expressed genes for the
datasets with external ‘gold standard’, while varying the FDR-adjusted p-value or posterior
probability cutoff, obtained with the shrinkage of variance as opposed to the proposed
shrinkage of dispersion. Sub-columns are subsets of the data with one randomly selected
replicate per condition, and the full available datasets. Values closer to 1 indicate higher
sensitivity and specificity. The areas under the ROC curves are smaller than the values in
the first row of Table 3.2
Simulation1 Simulation2 Simulation3 MAQC Project Griffith et al.
n = 1 n = 2 n = 1 n = 2 n = 1 n = 2 n = 1 nA=4, nB=2 n = 1
0.605 0.863 0.654 0.885 0.602 0.506 0.597 0.522 0.646
most consistently the expected pattern, and had a similar or a higher accuracy as compared
to the existing methods.
Table 3.3 and Fig. 3.6 show the details of detecting differentially expressed genes while
shrinking the method of moments estimates of variance, as opposed to the proposed shrink-
age of dispersion. They illustrate that shrinking the variance undermines the accuracy of
the results.
3.5.3 Effect of sample size
To study the effect of sample size, we repeated simulation3 for ni = 1, 2, 3, 4, 6, 8, 10.
Table 3.4 summarizes the performance of the proposed method, as well as of DESeq and
edgeR with both the exact test and the generalized linear model-based approach. The results
indicate that sSeq is particularly advantageous for experiments with ni ≤ 4.
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(1) Brook (2) Sultan (3) Bottomly (4) Hammer (5) Tuch
—–nA1=nA2=1 —–nA1=nA2=1 —–nA1=nA2=1 —–nA1=nA2=1 —–nA1=nA2=1
· · · nA=nB=1 · · · nA=nB=1 · · · nA=nB=1 · · · nA=nB=1 · · · nA=nB=1
- - - nA=nB=2 - - - nA=nB=2 - - - nA=10, nB=11 – · – Full dataset – · – Full dataset
p-value p-value p-value p-value p-value
Fig. 3.6.: The empirical cumulative distribution function (ECDF) curves of detecting differ-
entially expressed genes for the five datasets with no external ‘gold standard’ when shrink-
ing the variance estimates. Y-axis: ECDF, function of the gene rank. X-axis: p-value.
Solid line: unreplicated comparison AvsA. Dotted line: unreplicated comparison AvsB.
Dashed line: AvsB on the full dataset for two-group designs. Dotted-dashed line: AvsB
on the full dataset for more complex designs. Gray line: 45 degree. The curves are less
consistent with the expected patterns than the curves in the first column of Fig. 3.2.
3.5.4 Effect of size factors
Table 3.5 the true and the estimated size factors for the ten datasets in this manuscript.
The estimates are obtained with the proposed approach (i.e. are identical to the estimates
by DESeq).
To investigate the effect of the estimates of size factors on the accuracy of the results, we
conducted an additional evaluation for the three simulated datasets with nA = nB = 2, and
for the methods that assume a Negative Binomial distribution. Table 3.6 shows the results
of the original implementation of each method. Note that edgeR and baySeq estimate
size factors on the total count scale, while the other methods use a relative scale. edgeR
multiplies the total library size by the output of calcNormFactors. baySeq uses the
total library size directly.
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Table 3.4: Areas under the ROC curves of detecting differentially expressed genes for the
Simulation3 when the number of samples increases. Values closer to 1 indicate higher
sensitivity and specificity
ni = 1 2 3 4 6 8 10
sSeq 0.856 0.888 0.903 0.913 0.917 0.926 0.929
edgeR 0.840 0.833 0.844 0.852 0.869 0.875 0.871
DESeq 0.842 0.815 0.885 0.894 0.907 0.914 0.915
baySeq 0.558 0.628 0.628 0.620 0.616 0.609 0.603
BBSeq 0.578 0.619 0.601 0.613 0.610 0.591 0.607
SAMseq - 0.882 0.897 0.903 0.916 0.925 0.926
GLM edgeR - 0.799 0.898 0.878 0.943 0.946 0.956
GLM DESeq - 0.828 0.832 0.831 0.835 0.834 0.831
Table 3.7 uses the size factors estimated by sSeq (equivalently, by DESeq) with the two
other methods. The size factors were converted to the appropriate scale by multiplying the
total library sizes by the size factor estimates of sSeq and DESeq.
Table 3.8 uses the true size factors with all the methods. The size factors were converted
to the appropriate scale for edgeR and baySeq by multiplying the total library sizes by the
true simulated size factors.
To summarize, the results showed that size factors do indeed play a role in the accuracy
of the results. Importantly, the changes did not affect the conclusions of the manuscript.
The proposed method sSeq consistently showed a strong performance, except in Simula-
tion3 where baySeq combined with a better size factor had a higher area under the ROC
curve.
3.6 Discussion
In this manuscript we advocated a model that specifies free per-gene dispersion param-
eters in the Negative Binomial model for counts of RNA-seq reads. We also advocated
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Table 3.5: The true and estimated size factors for the ten datasets. The estimates are ob-
tained with the proposed approach (i.e. equivalent to DESeq). The true values of size
factors are only available for simulated datasets
sAj sBj
Datasets True Estimated True Estimated
Simulation1 0.6, 1.5 0.684, 1.729 0.8, 0.7 0.987, 0.866
Simulation2 0.6, 1.5 0.686, 1.732 0.8, 0.7 0.984, 0.863
Simulation3 1.3, 1.6 1.006, 1.196 1.4, 0.9 1.126, 0.749
MAQC 0.966, 1.202, 1.023 0.516, 1.706
Griffith et al. 1.317 0.760
Brooks 1.297, 1.042 0.819, 0.911
Sultan 0.917, 0.862 1.160, 1.132
Bottomly between 0.578 and 1.524 between 0.756 and 1.616
Hammer 1.038, 0.897 1.027, 1.065
Tuch 0.719, 0.831, 1.753 0.627, 1.084, 1.424
a biased estimation of these parameters, which can reduce the variance of the estimates
and minimize the overall mean squared error. Biased estimation is different from specify-
ing a probability model (such as in DESeq) that assumes a true systematic relationship of
the true variance and the true mean. It is particularly useful for experiments with a small
sample size, where the systematic relationship may be difficult to evaluate. The shrink-
age estimates are easy to compute, avoid iterative estimation, minimize the potential for
overfitting, and do not require extra computation time. They are compatible with the exact
test of differential expression. For the datasets in this manuscript, sSeq consistently had a
similar or a higher sensitivity and specificity of detecting differential expression than the
existing methods. The approach can be generalized to express the dependence of the dis-
persions on the expected value, or on other covariates such as GC content or Gene Ontology
annotations.
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Table 3.6: The estimates of the size factors by each method, and the corresponding areas
under the ROC curves for the three simulated datasets
Estimates ŝij by each method AUROC













































Table 3.7: Areas under the ROC curves for edgeR and baySeq for the three simulated
datasets, while using the size factors estimated by sSeq (equivalently, by DESeq)
Estimates ŝij by sSeq (and DESeq) AUROC






























Table 3.8: Areas under the ROC curves for edgeR and baySeq for the three simulated
datasets, while using the true values of size factors used for the simulations
True size factors sij AUROC
Sim1 Sim2 Sim3 Sim1 Sim2 Sim3






























sSeq can produce meaningful results in under-replicated RNA-seq screens. However
we’d like to stress that RNA-seq screens do not eliminate the biological variation in gene
expression [12]. As evidenced by Table 3.2 and Fig. 3.3, the under-replicated screens have
lower reproducibility as compared to the replicated studies. Multiple biological replicates
are necessary to adequately assess the full extent of the variation in the biological system.
Therefore the under-replicated screens can only be conducted when followed by a rigorous
experimental validation with complementary technologies and adequate sample size.
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4. MS/MS WITH SWATH AQUISITION
4.1 Introduction
Proteins are macro-molecules folded in three dimensions. A protein consists of one
or more peptides (i.e. chains of molecules that may chemically bind to the others). The
sequence information of peptides and their abundance can be used for protein identification
and quantification.
A well-known technique, mass spectrometry (MS), is typically used to produce the
spectra of masses of the peptides in a sample, which are commonly named as MS1 spectra.
However, information from these spectra is not specific enough to distinguish the peptides
that have the same or similar masses and co-elute in the same time. Since different peptides
consist of different fragments, the MS2 spectra of the masses of the peptides’ fragments
are required for peptide identification and quantification. This technique is Tandem mass
spectrometry (MS/MS) that generates MS1 and MS2 spectra.
The methods used for target approach are Selected Reaction Monitoring (SRM) or
Multiple Reaction Monitoring (MRM). They are well accepted methods that provide high
specificity and sensitivity for protein quantification. When profiling samples in MS/MS
instrumentation, specific peptides are selected. Prior knowledge (i.e. mass to charge ra-
tio and retention time) of those peptides is provided. Only the MS2 spectra of those se-
lected peptides’ fragments are generated through the instrument no matter how many other
peptides are presented in the sample. When additional peptides are selected, the samples
have to be profiled again through the instrument. This problem substantially increases the
experimental cost. Consequently, the Sequential Window Acquisition of All THeoreti-
cal fragment-ion spectra (SWATH) method is developed as a data-independent acquisition
(DIA) method. It provides MS1 and MS2 spectra for all the peptides in a sample at once.
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Instead of setting any prior knowledge for the instrument, the knowledge is utilized for the
post identification and quantification of targeted peptides.
Unlike SRM or MRM that scan the fragments of only one peptide in a MS2 spectrum,
SWATH produces a MS2 spectrum that includes the fragments of one or multiple peptides.
Such experimental design substantially alleviates the workload of MS/MS instrumentation.
This is a main reason why the SWATH acquisition method significantly reduces the ex-
perimental cost and shortens entire time period. In [5], it was illustrated that the SWATH
method can also provide good sensitivity and specificity in identification compare SRM.
However, it also brings challenges to the computational and statistical analysis of protein
quantification because data is more noisy than before.
4.2 Background
Specifically in a run of the SWATH experiment, for example, there can be 32 windows
for peptides (i.e. precursor ions) from 400-426 Da to 1175-1201 Da. At each step, a MS1
spectrum scans all the precursors. The MS2 spectra sequentially scan the fragments of the
peptides present in each of the 32 windows. The 32 fragmentations take about 3.2 seconds
to be completed. This procedure is repeated over thousands of times in a range of time
period between 0 and 120 minutes.
A publicly available software [5], openSWATH, can be utilized to pick up the peaks of
fragments based on eXtracted Ion Chromatograms (XICs). The purpose of using XICs is
to reduce the three-dimensional data (i.e. count, retention time, and m/z) of MS2 spectra
into the two-dimensional space (i.e. summed-up count and retention time). Practically, the
spectrum of a fragment ion is often centered on a specific m/z value and varies within a
50 ppm bin equivalent to (theoretical mass)×50×10−6 in dalton. The counts of molecular
ions that have m/z value within the 50 ppm bin are summed up to represent the abundance
of this fragment. Such ions are extracted at each point in time. The XIC of the fragment
consists of the summed-up counts across those ions. When a fragment is truly present in
the sample, there should be at least a peak observed in its XIC.
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After the intervals of retention time for all the observed peaks are estimated by openSWATH,
another systematic software mProphet can be used to filter out those problematic peaks ac-
cording to the pattern between the XICs of different fragments within the peptides. Com-
bining openSWATH and mProphet, it enables the successful identification of meaningful
peptides.
However, the previous methods just simply sums up the counts within the m/z bins
at each point in time. They ignore the problem that the ions within those m/z bins may
actually belong to different peptides but still generate large peak in the XIC over elution
time. This may leave undetected interference noise into fragment quantification. In this
project we argue that, in addition to the coherent pattern between XICs, it is challenging
but necessary to also quantify the homogeneous pattern within XICs.
4.3 Methods
When the ions profiled in the same m/z bins belong to the same peptide, their traces
over elution time share similar peak patterns. Motivated by this concept, we separate each
XIC into several miniXICs in the m/z dimension. Those miniXICs are generated in tiny
bins with a unit of 0.01 Da, and are utilized to account for the within-XIC information. We
propose to fit a linear quadratic regression model in those miniXICs. The probability of
having a negative quadratic coefficient is utilized to score the homogeneity of co-elution
peaks. Details are provided as follows.
74
4.3.1 Per-fragment linear quadratic regression.
We denote ult,fpsg as the count in log scale for the molecules in the lth miniXIC at
point t in retention time for fragment f of peptide p in sample s under group g. We fit the
quadratic model Eq. (4.1) in all the miniXICs from fragment f .
ult,fpsg = β0,fpsg + β1,fpsgxt,psg + β2,fpsgx
2
t,psg + εlt,fpsg, (4.1)
for l = 1, 2, . . . , Lfpsg, t = 1, 2, . . . , Tpsg, and nfpsg = Lfpsg · Tpsg
with β2,fpsg ∼ N (µ2,fpsg, σ22,fpsg) and εlt,fpsg ∼ N (0, σ2ε,fpsg)
where xt,psg, β0,fpsg, β1,fpsg, and β2,fpsg are the independent variable, the intercept, the
linear coefficient, the quadratic coefficient. The characteristics of these model parameters
are interpreted in the following paragraphs.
The independent variable xt,psg corresponds to the index of point in retention time.
This value is the same for all the fragments within the same peptide. It should be no-
ticed that different peptides can have different spans of retention time. The scale of the
independent variable varies when fitting Eq. (4.1) in different fragments. As a result, the
scale of the estimates of the model coefficients can be also different for different fragments.
This makes the results not directly comparable between fragments. In order to avoid this
problem, the values of the independent variable are standardizes as shown in Eq. (4.2).
xt,psg = (t− t̄)/(Tpsg − t̄) and thus xt,psg ∈ [−1, 1] (4.2)






The intercept β0,fpsg represents the average height of peaks at the center. At each
point in retention time, the intensities of a fragment in the m/z dimension typically present
a bell shape centered at the true m/z value of that fragment. The miniXIC is a transection of
the bell in the retention time dimension. Consequently, the peak height of a miniXIC can
vary between the bottom and the largest intensity for the fragment. The intercept parameter
75
summarizes the common height across the miniXICs for fragment f of sample s in group
g, and the variation of height between miniXICs involves the model error parameter εlt,fpsg.
The linear coefficient β1,fpsg represents the location of apex in retention time. In the
retention time dimension, the peaks of miniXIC are not often centered around the middle
point in retention time. The linear coefficient is used to address this problem when the
quadratic coefficient is fixed. This is illustrated in Eq. (4.3) that re-formularizes Eq. (4.1).
The transformation indicates that the peak of XIC centers around β1,fpsg/(2β2,fpsg) which
can be a non-zero value.
ult,fpsg = β2,fpsg (xt,psg + β1,fpsg/(2β2,fpsg))
2 + εlt,fpsg + constant·,fsg (4.3)
where constant·,fsg = β0,fpsg − β21,fpsg/(4β2,fpsg)
In Fig. 4.4-Fig. 4.3 under column 2, the observed miniXICs are the black lines. The
fitted values using Eq. (4.1) are the read lines. In those graphs, we can see that the estimated
peak hight is not necessarily on the point of time xt,psg = 0. Furthermore, the position of
peak apex can be quite different from the center of retention time.
The quadratic coefficient β2,fpsg represents the peak shape, and its sign does matter.
In Eq. (4.3), it indicates that ult,fpsg reaches the maximum at x = −β1,fpsg/(2β2,fpsg)
when the peak shape parameter is negative, i.e. β1,fpsg < 0. On the other side, ult,fpsg
changes to have a convex shape when β1,fpsg > 0. The interference noise exists in such a
situation. It is stronger when β1,fpsg is larger, and diminishes when β1,fpsg reaches negative
infinity. Accordingly, we propose to calculate the probability of β1,fpsg < 0 and utilize this
probability to account for the potential effect due to the interference noise within a XIC.
Furthermore, in order to account for the random variation between miniXICs, we as-
sume that the quadratic coefficient follows a Normal distribution with a mean µ2,fpsg repre-
senting the common peak shape and a variance σ22,fpsg addressing variability among miniX-
ICs. This random factor shrinks per-miniXIC regression estimates towards a stable target
optimized through restricted maximum likelihood (REML) [99–101].
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We propose a score wfpsg that quantifies the strength of homogeneity in peaks of
miniXICs. First, we describe the hypotheses in Eq. (4.4) and specify the statistic in
Eq. (4.5) that follows a student t distribution under the null hypothesis H0 with the degree
of freedom as dffpsg = nfpsg − 3. The estimates of peak shape, µ̂2,fpsg, and the standard
error of those estimates are obtained using the open source R package lme4 [101] with
the function lmer. Finally, we calculate the score shown in Eq. (4.6) using the R package
stats with the function pt.
H0 : µ2,fpsg < 0 vs Ha : µ2,fpsg ≥ 0 (4.4)
statfpsg = µ̂2,fpsg/StandardError(µ̂2,fpsg) (4.5)









t,psg − x2t,psg)2. The
nominator in the formula of StandError is the total square of model residuals. It is affected
by both the variance of the model error σ2ε,fpsg and the variance of the random factor σ
2
2,fpsg
in Eq. (4.1). The graphs in Fig. 4.4 are the fragments of a peptide that have very low
weighting score, e.g between 0 and 0.004. Within the XICs of those fragments, the homo-
geneous patter between miniXICs (shown in column 1 and 2) is ambiguous. An example of
perfect peak shape can be shown by Fig. 4.1 row 2. The weighting score is 1. Furthermore,
Fig. 4.1 and Fig. 4.2 illustrate that a bell shape in peaks is not required for measuring the
homogeneity within the XIC of a fragment.
4.3.2 All-fragment linear quadratic regression for a peptide.
As an extension to the per-fragment modeling, the model in Eq. (4.1) can be changed
(shown in Eq. (4.7)) and fitted into the miniXICs across all the features within a peptide.
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The purpose of using this extended all-fragment model is to share information among frag-
ments.
ultf,psg = β0f,psg + β1,psgxt,psg + β2f,psgx
2
t,psg + εltf,psg, (4.7)
for l = 1, 2, . . . , Lfpsg, t = 1, 2, . . . , Tpsg,




with β2f,psg ∼ N (µ2f,psg, σ22f,psg) and εltf,psg ∼ N (0, σ2ε,psg)
Since the heights of different fragments are different, the model intercept β0f,psg should
be different upon f . For the linear coefficient, because the co-elution peaks of the frag-
ments from the same peptide should have centers very similar to each other, we use β1,psg
to account for the common position of apexes. Finally for the quadratic coefficient, we
preserve the assumption in Eq. (4.1) and allow different variance components for different
fragments. According to Eq. (4.8), we calculate the score that reflects the within-XIC vari-
ation based on the all-fragment model in Eq. (4.7). The degree of freedom in this model is
dfpsg = (npsg − 1)− 2× Fpsg.
statf,psg = µ̂2f,psg/StandError(µ̂2f,psg)
wf,psg = Probability(studenttdfpsg > statf,psg when H0 is TRUE) (4.8)
4.3.3 Evaluations
Fitting the linear fixed-effect model into the raw intensity. For each protein, Eq. (4.9)
is developed in [102] and utilized to detect any differential changes.
yfpsg = µ· + Ff + S(G)s(g) +Gg + εfsg (4.9)
with εfpsg ∼ N (0, σ2)
where µ· is the average intensity. Ff is the statistical fixed effect on the raw intensity yfpsg
due to fragment ion f in the protein. S(G)s(g) and Gg is the statistical effects due to subject
s and group g. This model is implemented in the open source R package SRMstats [102].
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The raw intensity can be either the total count under the XIC curve or the peak height of the
curve. The performance is illustrated in Fig. 4.6. Specifically, the term logCnt in the figure




t ult,fpsg. On the other
hand, the intensity can also be the estimated peak height of miniXICs, i.e. yfpsg = β̂0,fpsg
in the per-fragment model Eq. (4.1) or yf,psg = β̂0,sg in the all-fragment model Eq. (4.7).
Fitting the linear fixed-effect model with unequal variance adjusted by the weighting
score. After obtaining the probability score wfpsg for each fragment, we evaluate the
performance of the proposed score by comparing the results of protein differential analysis
using the weight or not. In the study of protein differential analysis, a linear fixed-effect
model for each protein shown in Eq. (4.9) is adjusted in Eq. (4.10). In order to weight the
raw intensity, we assume the model has unequal variance and adjust this heterogeneity by
the proposed weighting scorewfpsg. In Eq. (4.10), the parameters and variables are denoted




· + F∗f + S(G)∗s(g) +G∗g + ε∗fpsg (4.10)
with ε∗fpsg ∼ N (0, w2fpsg · σ2)
For the purpose of comparison, we use an alternative method, mScore, which is orig-
inally provided by the open source software mProphet [103]. It gives one value for one
peptide within a sample, and accounts for the between-XIC coherence across fragments.
The original purpose of using mScore is to control the false discovery rate. It linearly
combines several scores the quantify the coherent pattern between fragments within the
peptide. The smaller the value is, the stronger the pattern is. In order to make this alterna-
tive approach comparable to the proposed approach, we convert it into standardized value
in Eq. (4.11).
mScore = −log(m_score)/max(−log(m_score)) (4.11)
where m_score is the original value provided by the software. The standardized score
has values between 0 and 1. When mScore is greater, the between-fragment coherency is
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stronger. In order to adjust the raw intensity by mScore, the model assumption in Eq. (4.10)
is changed to be ε∗fpsg ∼ N (0, mScore2psg · σ2).
4.3.4 Dataset
A SWATH-MS experiment of yeast organism [5] involves two conditions, i.e. 0 minutes
(A) and 120 minutes (B). Three biological complex samples are processed under each of the
two conditions. There should be thousands of proteins in one complex sample, e.g. around
2200∼2340. The size of the raw data is large, such as 10∼22GB for just one run. Before
performing differential analysis for proteins, peptides and their fragments are identified by
Spectronaut and filtered by m_score. All the peptides that have m_score greater than 0.01
are considered as false identified. As a result, only the peptides that have m_score less than
0.01 are used for evaluation. Since the majority of the peptides are true, more than 50% of
them obtain the proposed weighting score wfpsg greater than 0.9.
The number of differentially changed proteins between A and B is expected to be larger
than the number of changed proteins between samples within condition A. The result of
comparison between A and B empirically reflects the sensitivity (i.e. AB), and the result
of comparison between samples within condition A can reflect the specificity (i.e.AA).
ECDF plots of p-values are utilized to visualize the efficacy of the proposed score. Such an
evaluation method has been used in [4].
4.4 Results
the ECDF curve of p-values for between-condition comparisons (AB) empirically indi-
cates the sensitivity. When it is closer to the top left corner, the method is more sensitive.
The ECDF curve of p-values for within-condition comparisons (AA) empirically indicates
the specificity. When it is closer to the 45 degree line, the method has higher specificity
and smaller false discovery rate.
The proposed score improves the result of protein differential analysis. In Fig. 4.6
(a)-(d), adjusting with the proposed score (termed as w) always increases both the sensitiv-
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points in time vs m/z points in time points in time
Fig. 4.1.: The proposed score is close to 1 when miniXICs of the fragment share homoge-
neous peak shape, illustrated by peptide AAADALSDLEIKDSK in sample s=1 and group
g=1. Column 1 is the three-dimensional barplots of intensities. Column 2 overlays the
miniXICs (black lines) and the fitted lines (red lines) with Eq. (4.1). The XIC plot of a
fragment shown in column 3 is the total intensity at each point in time based on the 3D
barplot shown in column 1. The X-axis in all the graph is the independent variable x in
Eq. (4.1) and Eq. (4.2).
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points in time vs m/z points in time points in time
Fig. 4.2.: The proposed score gives high weight to the fragment as long as an apex observed
in only a partial peak, illustrated by peptide YAQDGAGIER in sample s=6 and group g=2.
Axes and labels are as in Fig. 4.1.
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points in time vs m/z points in time points in time
Fig. 4.3.: The proposed score gives low weight to the fragment when its miniXICs
have flat pattern independently from the other fragments within the peptide AAQDSF
AAGWGVMVSHR in sample s=2 and group g=1. Axes and labels are as in Fig. 4.1. The
fragment with interference noise is illustrated in row (c).
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points in time vs m/z points in time points in time
Fig. 4.4.: The proposed score is close to 0 when the interference noise is strong, illustrated
by peptide SKLNDAVEYVSGR2 in a sample. Axes are as in Fig. 4.1.
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(1) raw intensity (2) proposed (3) alternative







































































































































































sample index sample index sample index
Fig. 4.5.: The proposed method succeeds in providing consistent weighting scores within a
sample or a fragment. The profile plots shown in this figure are fragments’ intensity versus
sample index. A connected line in the plot is the profile of a fragment. The first 3 samples
are under condition A and the last 3 samples are under condition B. This is illustrated by
the profile plots of the four peptides shown in Fig. 4.4-Fig. 4.3. The four peptides shown in
Fig. 4.4-Fig. 4.3 are presented in rows of this figure. It is shown that the weighting effect
of mScore is ignorable. Detailed information about the formulae and the interpretation are
provided in Chapter 4.3 and Chapter 4.3.3. The Y-axis in column 1 is the total raw intensity
under the XIC curve of a fragment. It is the dependent variable in Eq. (4.9). The Y-axis in
column 2 and 3 is the dependent variable in Eq. (4.10).
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(a) Per-fragment, peak height (b) Per-feature, log(totalCount)






























(c) All-fragment model, peak height (d) All-fragment model, log(totalCount)
Fig. 4.6.: The total intensity adjusted by the proposed weight score improves the accuracy
of testing results upon this dataset. AB and AA label the comparison between conditions and
the comparison within conditions. m.AB and m.AA are the quantification with estimated
peak heights. mw.AB and mw.AA are the products between peak heights and the weight-
ing score. logCnt.AB and logCnt.AA are the quantification with log of total count.
logCnt_w.AB and logCnt_w.AA are the products between logCnt and the weighting
score (see Chapter 4.3.3 and Chapter 4.4 for details).
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per-fragment model 
- - - AA        AB
all-fragment model   
- - - AA        AB 
(a) The proposed weighting scores
per-fragment model





























Fig. 4.7.: The comparison between per-fragment models and all-fragment models indicates
that they are competitive. (a) The smooth scatter plot of all-fragment model vs per-fragment
model indicates that the most of the scores are similar since the majority is around the 40
degree line. The dark colored area at the top right indicates that more fragments obtained
the weight close to 1 using all-fragment model than using per-fragment model. (b) The
ECDF plot indicates that the proposed score using per-fragment model helps to increase
specificity in tests and moderately sacrifice sensitivity compare all-fragment model.
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(a) The proposed scores versus 
the alternative scores




















Fig. 4.8.: The proposed score outperforms the alternative score by increasing specificity
in tests. (a) In this smooth scatter plot, mScore is standardized to be comparable with
the proposed score. Details are provided in Chapter 4.3.3 The data shown in this plot is
already filtered so that all the fragments have strong coherent pattern within the peptide.
The purpose is to show that the proposed score is complementary to the existing alternative.
It further improves the accuracy in test based on the filtration result from mProphet. (b)
In the ECDF plot, axes and labels are as in Fig. 4.6. Per-fragment model is used for the
proposed score. The ECDF curve of p-values for the within-condition comparison using the
proposed score is much lower than the curve using the alternative. It indicates the reduction
of false discovery rate.
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ity and specificity. For example, mw.AB always has a higher curve than m.AB. And mwAA
always has a lower curve than m.AA. The same result can be observed for logCnt and
logCnt_w. This result illustrates that adjusting fragments’ intensity with the proposed
weighting score sufficiently powerful to increase the accuracy for the differential analysis
of proteins.
The total intensity is better than the peak height for quantification. The total inten-
sity is the summed-up counts under the XIC peak. This quantification method is currently
used by the open source software Spectronaut. In Fig. 4.6, it is also observed that us-
ing the weighted peak heights to quantify fragments’ abundance (i.e. mw.AB and mAA) can
obtain similar sensitivity but much less specificity than the quantification based on the total
intensity (i.e. logCnt_w.AA and logCnt_w.AB. Therefore, from now on, we further
evaluate the proposed score by focusing on the quantification based on the total intensity in
log scale.
Per-fragment models and all-fragment models are competitive. For the purpose of
borrowing common information across fragments with the peptide, all-fragment models are
proposed. The ECDF plot in Fig. 4.7 illustrates that the all-fragment models return higher
intensity but slightly lower specificity. Howver, the difference is not as significant as the
difference from the other approaches shown in Fig. 4.6.
The proposed score outperforms the alternative. As an existing weighting method,
mScore (provided by the open source software mProphet is used to adjust the intensity
of fragments. The result using this existing score is exemplified in Fig. 4.5 (column 3) and
evaluated in Fig. 4.8. While increasing the sensitivity logCnt_mScore.AB in Fig. 4.8,
the specificity logCnt_mScore.AB is substantially decreased. However, the result using




In the SWATH experiments, MS1 and MS2 spectra are obtained using a data-independent
approach through instrumentation. They are then analyzed using a target approach for iden-
tification and quantification. Currently existing methods provide identification and quan-
tification analysis based on the extracted ion chromatography (XIC) within the m/z bins.
The variabilty between XICs of different fragments is addressed. However, the interfer-
ence noise within a XIC is not yet accounted for. We propose a score that quantifies the
strength of the homogeneous peak pattern among miniXICs within a XIC. This score is
utilized as a weight. The intensity of a fragment obtained from its XIC is multiplied by
the proposed score. The evaluation result indicates that both the empirical sensitivity and
specificity of protein differential analysis are substantially improved. It also illustrates that
the proposed score outperforms the alternative such as mScore provided in the open source
software mProphet.
When calculating the proposed score, two models are proposed with different approaches.
Per-fragment modeling emphasizes that the within-XICs variation is independent between
different fragments. The homogeneity within a XIC is totally un-related to that within an-
other XIC even though the two fragments may come from the same peptide. In order to
avoid any potential mis-communication between genuine fragments and artificially identi-
fied fragments, per-fragment model is recommended.
Another approach is all-fragment modeling. It assumes that the identified fragments for
a peptide are jointly genuine or jointly artificial. If the majority of the fragments present
strong interference noise, the other fragments from that peptide are also weighted down.
When all the identified fragments are truly from the same peptide, all-fragment modeling is
sufficiently powerful to rescue the low-abundant fragments. It is illustrated in Chapter 4.4
that this approach increases the empirical sensitivity and moderately sacrifices the empirical
specificity.
Furthermore, a discussion may involve the appropriateness of the fixed-effect modeling
used for evaluation. The model in Eq. (4.9) (implemented with the open source R package
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SRMstats) assumes that the variance component of model error εfsg is common across
fragments. However, this assumption may not always be satisfied. Especially when the
statistical interaction between fragment and model error is significant, a model with the
assumption of unequal variance components may be required. However, the diagnosis of
residuals needs to be performed before accounting for the unequal variance in a new model.
For example, the presence of un-equal variance can be indicated by a strong association
between absolute model residuals and the factor of fragments.
Finally, this chapter proposes a weighting score to adjust fragments’ intensities in order
to account for the within-XIC variation. Although the proposed approach increases the
empirical sensitivity and specificity, the accuracy of protein differential analysis can be
further improved by removing artificially identified fragments from the model fitting. The
approach of feature selection with machine learning or data mining methods will be further
developed in future research.
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5. SUMMARY AND FUTURE RESEARH
In this thesis, we focus on the problem of estimation of variation that involves three types
of important high-throughput biological molecular experiments. Because different exper-
imental designs generate datasets with different characteristics, we propose different sta-
tistical methods to account for sources of variation. For the purpose of reducing noise
in perturbation experiments in Chapter 2, we utilize the information from controls sam-
ples, and propose to stepwise estimate the additive and non-additive effects with linear
mixed-effect models. In order to reduce the variation of variance estimates in the Negative
Binomial models in Chapter 3, we propose to shrink the dispersion estimates towards a
common information borrowed across genes. Finally in Chapter 4, working directly with
large raw data (i.e. 10∼25 GB), we propose a score that quantifies the strength of homo-
geneity within signals identified for a fragment. The purpose of the proposed method is
to weigh down the fragment identified by openSWATH that actually consists of the ions
generated from different peptides.
In future research in perturbation screens, gene-gene interaction can be identified from
the analysis of pairs of gene perturbation instead of single gene perturbation. The number
of mutant samples is much greater. The sources of additive and non-additive variance are
more complicated. Further research with new statistical modeling is required.
RNA-seq experiments are considered as a complementary or even substitute method of
microarray experiments for gene expression analysis. The tools and methods of processing
and analyzing RNA-seq experiments are developing rapidly. Instead of developing methods
for RNA-seq itself, a challenging but promising approach can be combining it with the
other meaningful experiments, such as ChIP-seq experiments.
In the analysis of SWATH experiments, future research can endeavor to implement new
models with unequal variance model error in the step of protein differential analysis. This
new model needs to be applied especially when diagnosis of model residuals indicates the
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significant dependence between the absolute residuals and the factor of fragments. Further-
more, the feature selection or machine learning methods (e.g. LASSO, ridge regression, or
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